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The ability to predict is one of the hallmarks of successful theories.  Historically, 
the predictive power of biology has lagged behind disciplines like physics because the 
biological world is complex, challenging to quantify, and full of exceptions.  However, in 
recent years the amount of available data has expanded exponentially and biological 
predictions based on this data become a possibility.  The functional gene network is a 
quantitative way to integrate this data and a useful framework for making biological 
predictions.  This study demonstrates that functional networks capture real biological 
insight and uses the network to predict both subcellular protein localization and the 
phenotypic outcome of gene knockouts.  Furthermore, I use the functional network to 
evaluate genetic modules shared between diverse organisms that lead to orthologous 
phenotypes, many that are non-obvious.  I show that the successful predictions of the 
functional network have broad applicability and implications that range from the design 
of large-scale biological experiments to the discovery of genes with potential roles in 
human disease. 
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Chapter 1: Introduction to predictive biology and functional networks 
In science, predictive, quantitative theories and models are preferred over post-
hoc, qualitative theories, because they are both useful for guiding further research and 
indicate that our models are not just rationalizing data, but providing genuine insight into 
the workings of the system under question.  Historically, physics has been the field of 
science best known for its ability to predict the phenomena in its domain; however, 
biologists also value predictive models and in recent years a renewed emphasis on 
prediction has accompanied the rise of systems biology [1].  Some efforts have used 
explicit modeling of physics and chemistry, using diffusion and reaction rates to model 
biological systems.  One classic example is the von Dassow et al. computational model of 
the formation of the segment polarity stripes during early Drosophila development, which 
incorporated known molecular details and showed that the model recapitulated the 
biology over a wide range of values for parameters that were unknown [2].  
Unfortunately, this type of explicit modeling is limited to well studied systems.  Perhaps 
the longest running collaborative effort for biologically relevant predictions is in the area 
of predicting protein structure.  Since 1994, a series of competitions, Critical assessment 
of techniques for protein Structure Prediction (CASP), have evaluated the performance of 
many different approaches to predicting protein structure including: ab initio approaches 
using molecular dynamic simulations, homology based structure prediction, and fold 
recognition [3].  More recently, Scott et al. attempted to predict subcellular protein 
localization using a customized Bayesian classifier [4] and previously known data [5, 6].  
Finally, the entire field of functional genomics sprung up to predict the function of the 
large number of new genes identified by genome sequencing by extrapolating from 
known functional data.   
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Predictions in biology remain challenging.  Part of the challenge is to identify the 
areas of biology that are tractable for prediction and that will make the greatest 
contribution to our understanding of life.  As with other disciplines, it is very important to 
identify the optimal scope of the research, aim for incremental progress, and make readily 
testable hypotheses.  In the following, I will discuss my first effort to test a reasonably 
ambitious prediction, which failed, and evaluate it by these criteria.  I will end the chapter 
with a discussion of the conclusions that guided my future attempts at prediction. 
 
PREDICTING THE NUCLEAR EXPORT ADAPTOR OF THE RIBOSOME SMALL SUBUNIT. 
The formation of the ribosome is a complicated, multi-step process that starts in 
the nucleus and finishes in the cytoplasm.  The ribosome’s two subunits, the large subunit 
(LSU) and the small subunit (SSU), start as a single nuclear RNA transcript, which is 
cleaved into two pieces.  Each RNA molecule separately undergoes further processing 
and the integration of structural proteins within the nucleus.  After key steps are finished, 
the subunits are exported to the cytoplasm for further processing; however, until recently, 
the nuclear export adaptors for both subunits were unknown.  Nuclear export adaptors 
physically link their cargo to the export machinery of the nuclear pore, typically CRM1, 
to provide directed transport across the nuclear membrane.  In 2000, Ho et al. reported 
the discovery of the yeast nuclear export adaptor for the ribosome large subunit (LSU), 
NMD3 [7].  Thus far, the nuclear export adaptor for the ribosome SSU has not been 
identified.  So, I decided to test the hypothesis that the ribosomal SSU nuclear adaptor 
can be predicted based on properties of the LSU adaptor.  I collaborated with Arlen 
Johnson, who had originally identified the LSU adaptor, on this project. 
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Method for predicting the SSU adaptor 
My prediction strategy was based on the assumption that key properties of the 
LSU nuclear adaptor, NMD3, can serve as a guide to identify SSU export adaptor 
candidate genes.  Several properties of NMD3 serve as logical starting points for finding 
the SSU adaptor. NMD3 is essential, as would be expected of a gene critical to the 
function of core cellular machinery.  NMD3p has a classical nuclear export sequence 
(NES), which is known to interact with CRM1 during export.  NMD3 is a conserved 
protein across archeal and eukaryotic organisms, with an additional domain in eukaryotes 
containing the NES that is not present in the archea, which lack a nuclear membrane.  
Furthermore, NMD3 contained a nuclear localization sequence (NLS), which allows it to 
recycle to the nucleus after delivering the nascent SSU to the cytoplasm. 
 
I created a flexible scoring scheme that integrated multiple criteria, since it was 
unclear which criteria would be most useful for identifying the SSU: essentiality, 
presence of a nuclear export sequence, links to the SSU and/or nuclear export machinery 
in the functional network, the distribution of the protein across eukarya and archea, and 
haploinsufficiency.  I integrated the scoring scheme into a web-based application to 
simplify the exploration of various combinations and weighting of criteria and to 
facilitate collaboration.  In addition, I created a simple tool to compare the results from 
various weightings of the evidence.  The underlying data was obtained from the 
following: essentiality and haploinsufficiency from SGD [8], nuclear export sequence 
prediction from NetNES [9], functional links from a pre-publication version of YeastNet 
v.2. [10], and protein conservation using Blast (data provided by Insuk Lee). 
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I explored various combinations of requirements and scoring schemes.  Across a 
wide range of parameters, NMD3 was recovered as a top candidate, which suggested that 
our approach could identify the SSU adaptor if it resembles the LSU adaptor in its mode 
of action. 
 
Approach to experimental testing of SSU adaptor predictions 
After comparing the results from multiple criteria weightings, we hand selected 
five top candidates, including NOP1, PNO1, SUI3, for initial testing, with plans to screen 
additional candidate genes once the screening approach was validated and tested for 
scalability.  We assayed each gene for nuclear export activity in the following manner.  
We engineered dominant negative versions of each gene with a defective nuclear export 
sequences.  If the candidate is the SSU adaptor, over-expression of the dominant negative 
version is expected to block export of the SSU, shifting the distribution of GFP labeled 
SSUs from the nucleolus and cytoplasm to the nucleus. 
 
For each gene, the dominant negative was constructed in two PCR steps, followed 
by cloning into an inducible over-expression vector.  In the first step, the 5’ end of each 
gene was amplified using a forward primer containing an enzyme restriction site and a 
reverse primer that mutated nucleotides in the NES to mutate functionally important 
codons from leucine to alanine.  The 3’ end was amplified in a similar manner, with the 
forward primer designed to match the mutant nucleotides at the NES and the reverse 
primer containing a restriction site compatible with the expression vector.  In the second 
step, the PCR products of the first reactions were fused by amplifying with the forward 
primer of 5’ reaction and the reverse primer of the 3’ reaction.  Only molecules resulting 
from the overlap of the mutated NES region are amplified.  The mutant gene was then 
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cloned into a galactose inducible over-expression vector and co-transformed into yeast 
with a plasmid expressing a GFP tagged SSU protein.  Transformed strains were 
incubated in galactose media prior to microscopy to activate over-expression of the 
dominant negative.  A strain transformed with mutant NMD3 and a GFP tagged LSU 
protein served as a positive control. 
 
Experimental results 
Four of the most promising candidates were screened and found not to affect the 
distribution of the SSU.  The mutant form of NOP1 appeared to affect growth, so a rescue 
experiment was performed by adding a potent NES to the N-terminus of the protein.  The 
exogenous NES failed to rescue the growth phenotype, which suggests that the cause of 
the mutant phenotype is the destabilization of protein structure rather than the disruption 
of nuclear export.   
 
Evaluation of first predictive effort 
Upon reviewing the data, the methodological challenges and timeline, I decided 
that extending the screen to a larger number of genes would be a large investment with an 
ambiguous conclusion.  The predictions were highly dependent on the assumption that 
the SSU adaptor would operate with the same basic mechanism as the LSU adaptor, 
which was reasonable, but not guaranteed.  Unfortunately, in the case, the approach 
would not work unless we precisely identified both the specific gene and specific 
mechanism.  Interestingly, recent work has suggested that one of the predicted genes, 
PNO1 (also known as DIM2), may be involved in nuclear export, but its role as the 
adaptor has not yet been proven [11]. 
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Given the challenge of this approach, it become clear that the predictive power of 
the functional network should be tested in system that is easy to assay, which has more 
than a single target, and, requires a minimal number of assumptions and auxiliary data.  
The final requirement was needed so that the method developed would be broadly 
applicable rather than being rendered obsolete by its own success. 
 
NEW QUANTITATIVE, PREDICTIVE APPROACH WITH THE FUNCTIONAL NETWORK 
In my attempt to find a more broadly applicable approach to prediction, I chose 
one of the most generally applicable tools for inferring the function of unknown genes, 
which was first developed by Lee et al. in 2004 [12].  Their probabilistic functional 
network uses a Bayesian framework to integrate many types of biological datasets (e.g. 
protein interactions, transcriptional co-regulation, and gene fusions).  Abstracting the 
specific nature of interactions allows network to report the probability that two genes are 
functionally related without specifying the precise nature of the association.  Each data 
set integrated into the network is evaluated for quality by calculating the likelihood that 
two genes in a pathway will be linked by the evidence.  The cumulative evidence from 
multiple data sets can lead to well supported linkages that are poorly supported in any 
one experiment.  The network has already proven useful for predicting the function of 
genes involved in chromatin modification and ribosome biogenesis [12-14].  
Furthermore, the functional network provides an intuitive conceptual framework with the 
potential for novel application.  In order to make other predictions with the network, we 
took advantage of an established principle for inferring gene function from network 
connections, the principle of guilt-by-association (GBA).  In GBA, the function of 
uncharacterized genes is inferred from the functions of characterized neighbors in the 
network ([15-17]; reviewed in [18]).  The functional network is weighted, so, given a set 
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of genes with a property of interest, e.g. subcellular localization or knockout phenotype, 
other genes can be predicted based on the sum of their weights to that set.  I will provide 
greater detail for this general approach and specific applications in the following 
chapters. 
 
Applications of the functional network and new predictive approaches 
I have successfully tested two different applications of the functional network 
(discussed in chapter 2 and 3) and have leveraged it to help understand a novel predictive 
method which I will present in chapter 4. 
 
In chapter 2, I show that the functional network is a useful predictor of protein 
localization.  After a large genome wide screen for proteins localized to the yeast shmoo 
tip missed a large number of known genes, I developed a classifier for predicting 
additional proteins localized to the shmoo tip.  The initial set of 37 proteins from large 
screen was used to train a classifier and the top predictions were tested by hand in a small 
manual screen.  The classifier-guided retesting strategy doubled the coverage of the 
screen and remaining false negatives could be rationalized based upon low protein 
abundance. 
 
In chapter 3, I show proof-of-principle that genes linked in a functional network 
are likely to give rise to the same loss-of-function phenotype, demonstrating efficacy for 
predicting yeast mutant phenotypes.  I show that diverse yeast gene loss-of-function 
phenotypes are predictable, from biochemical to morphological to fitness effects.  The 
approach I describe provides a rational and quantitative foundation for targeted reverse 
genetic studies, which I demonstrate by predicting, then verifying, essential genes whose 
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disruption produces elongated yeast cells.  The breadth of applicability suggests that this 
approach could be implemented to identify genes likely to lead to human disease by 
leveraging extensive functional genomics data to expand sets of known disease genes by 
predicting new candidate disease genes. 
 
Finally, in chapter 4, I predict phenotype through a novel method that identifies 
equivalent phenotypes between species.  Mapping between genotype and phenotype is 
often non-obvious, complicating prediction of genes underlying specific phenotypes. I 
address this problem through comparative analyses of phenotypes. I define orthologous 
phenotypes between organisms (phenologs) based upon overlapping sets of orthologous 
genes associated with each phenotype. Genes known to have a phenotype in one 
organism become predictions for having the orthologous phenotype in the other 
organism.  Comparisons of >189,000 human, mouse, yeast, and worm gene-phenotype 
associations reveal many significant phenologs, including novel non-obvious human 
disease models. For example, phenologs suggest a yeast model for mammalian 
angiogenesis defects and an invertebrate model for vertebrate neural tube birth defects. 
With collaborators, we use the former to discover that SOX13 regulates vertebrate 
angiogenesis; with the latter, we demonstrate that IFT140 and RFX2 knockdowns cause 
neural tube defects. Phenologs create a rich framework for comparing mutational 
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Chapter 2: Predicting protein localization to the yeast shmoo 
INTRODUCTION 
Cells coordinate a large scale re-arrangement of their internal machinery when 
they undergo polarized growth.  Polarized growth is a fundamental, highly conserved, 
cellular process that is necessary for both basic cell division and a number of specialized 
growth patterns, for example, during development [1] and the formation of neuronal 
processes.  The budding yeast, S. cerevisae, is a common model organism for studying 
polarized growth, which adaptively re-uses the polarization machinery for vegetative 
growth, mating, and filamentous growth [2].  During normal cell division by budding, 
yeast orient their growth relative to the site of their last bud.  However, during mating, 
the direction of growth is determined by a pheromone gradient that allows cells to extend 
a mating projection, the shmoo, toward cells of the opposite mating type.  In each case, 
the cell’s morphological rearrangement is accompanied by a number of other changes, 
including changes in protein localization. 
 
When exposed to pheromone, yeast cells arrest in the G1 phase of the cell cycle 
and extend a shmoo up the gradient of the pheromone.  As the cell extends the shmoo, it 
re-orients various components of the cellular machinery along the new axis of 
polarization.  Many of the processes involved in budding are also used in shmoo 
formation; however, there are a number of differences as well.  Morphologically, the 
shmoo neck does not become as constricted as the bud neck and a number of proteins 
involved in pheromone sensing are not part of the budding process. Furthermore, the 
functional outcomes, the nuclear segregation and cytokinesis of budding versus the cell 
fusion and karyogamy of mating, entail a number of other different processes. 
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Although a number of shmoo related genes have been localized to the shmoo (e.g. 
shmoo marker, Fus1 [3]), previous proteome-wide screens have not yet characterized the 
shmoo-dependent re-localization of proteins.  My collaborators on this project [4] 
developed a cell micro-array based imaging assay that can characterize the spatial 
distribution of proteins throughout the cell by simultaneously surveying several thousand 
yeast strains with GFP tagged proteins.  The cell chip, a new technology for high-
throughput microscopy, was recently developed by a collaborative effort of several labs 
at the University of Texas at Austin [5].  The method involves the parallel treatment and 
fixation of thousands of yeast strains, which are then printed on a microscope slide using 
technology similar to the Stanford style microarray.  In this project, the library of yeast 
strains with GFP tagged proteins were exposed to alpha factor, a yeast mating 
pheromone.  The method is outlined in Figure 2.1 and reported in Narayanaswamy et al 
[5].  The initial genome-wide screen identified 37 genes localized to the shmoo; however, 
the screen only identified 6 of 47 genes annotated in the literature (as reported by the 
Saccharomyces Genome Database, SGD [6]) as localized to either the shmoo or the 





































FIGURE 2.1  SCHEMATIC OF CELL CHIP METHOD WITH PREDICTIONS.  First, the cell 
chip is screened to identify shmoo genes and the functional network is constructed 
independently.  Second, genes identified in the screen are used to train a network 
based classifier.  Finally, a manual screen of predicted genes recovers additional 
shmoo localized genes.  Adapted from [4]. 
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High throughput genome-wide screens are notoriously prone to false negatives 
[7], usually due to technical reasons and the possibility of human error when thousands of 
yeast strains are being assayed.  In this case, the high false negative rate may be due to 
fixation induced auto-fluorescence, which reduces the signal-to-noise ratio and obscures 
lower abundance proteins.  When we realized that the false negative rate of the automated 
screen was high, we asked whether a targeted manual screen might recover additional 
shmoo localized proteins more efficiently than re-screening the entire library.  We 
created a classifier to predict additional shmoo genes using the genes identified in the cell 
chip assay as a training set and manually screened the set of predicted genes.  The follow 
up screen identified an additional 37 shmoo localized proteins and together established a 




The genes identified in the high throughput screen were used to train a naïve 
Bayesian classifier (using the machine learning tool, Weka). Six genes annotated as 
mitochondrial proteins were manually removed from the set to avoid training on them, 
since they were potentially false positives.  Features were aggregated from data from the 
UCSF GFP screen [8] and the pre-publication YeastNet v.2  functional network by Lee et 
al. [9].  The features included for each gene were: the sum of log likelihood scores (LLS) 
to the set of shmoo genes, the ratio of the LLS sum linking genes to the shmoo set 
divided by the LLS sum of the gene’s links to all genes in the network, estimated protein 
abundance (molecules per cell), and cell location during growth in rich media (in the 
absence of pheromone).  The test set of 5804 genes, labeled as shmoo or not-shmoo was 
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also used as the both the training set and test set. Ten-fold cross validation had very 
similar results. The area under the ROC curve was 0.843, which indicates that it is a 
reasonably accurate classifier.  After training, the classifier recovered 20 of the 37 shmoo 
genes (cross-validation: 19). An additional 151 (cross-validation: 153) genes not 
identified in the initial screen were also classified as shmoo genes using a 0.5 probability 
cutoff.  The classifier was constructed in collaboration with Matt Davis. 
 
Testing predicted shmoo genes 
For the manual secondary screen, proteins predicted to be shmoo localized were 
tested in strains from the S. cerevisiae GFP tagged clone collection (Invitrogen). The 
collection consists of strains derived from the strain EY0986 (ATCC 201388: MATa 
his3∆1 leu2∆0 met15∆0 ura3∆0 (S288C)) by chromosomally tagging ~4200 genes with 
Aequorea Victoria GFP (S65T) at the carboxy-terminal end of an open reading frame 
[10].  We inoculated GFP strains from -80°C stocks into YPD in 96 well plates, grew 
them overnight, exposed them to alpha factor for three hours, and imaged them on a 
fluorescent scope.  Two graders independently scored cell images for shmoo localization 
of the GFP signal.  Proteins were considered shmoo localized when both grader’s agreed.  
Microscopy for classifier predicted genes was performed in collaboration with Ram 
Narayanaswamy. 
 
Additional related methods, which I was not involved in, are published in 




Shmoo localized proteins can be predicted from their functional linkage to known 
shmoo proteins. 
In order to expand our recovery of yeast proteins,  we combined genome-wide 
datasets of protein localization in yeast cells growing in the absence of pheromone [10] 
and the integrated probabilistic gene network [9, 11] to develop a classifier for predicting 
additional proteins localized to the shmoo tip (for example, proteins that had been missed 
because of low expression or penetrance). As detailed in the Methods, our initial set of 37 
proteins from the cell chip screen was used to train a naïve Bayesian classifier (Table 
2.1). Application of the classifier identified 151 proteins exceeding a 50% probability 
score threshold.  With a limited set of candidate genes, we could individually assay them 
in the absence of fixative.  118 of the 151 proteins were already present in the extant GFP 
library. We manually re-tested each of these 118 GFP fusion strains for protein 
localization to the shmoo tip. From this set, 37 additional proteins (~31% of those tested) 
were confirmed to be shmoo-localized (Table 2.2). 
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TABLE 2.1: MANUALLY VERIFIED SHMOO TIP LOCALIZED GENES IDENTIFIED BY 
THE CELL CHIP.  As in [4]. 
Gene name ORF name 
Human 
ortholog* 
Gene Ontology biological process 
annotation 
ABP1 YCR088W DBNL 
establishment of cell polarity (sensu 
Fungi) 
AIP1 YMR092C WDR1 response to osmotic stress 
BEM3 YPL115C - pseudohyphal growth 
CAP1 YKL007W CAPZA2 barbed-end actin filament capping  
CAP2 YIL034C CAPZB filamentous growth 
CAR1 YPL111W ARG1 arginine catabolism to ornithine  
CBK1 YNL161W STK38L regulation of exit from mitosis 
CDC10 YCR002C SEPT9 cell wall organization and biogenesis 
CDC11 YJR076C - cell wall organization and biogenesis 
CDC48 YDL126C VCP ubiquitin-dependent protein catabolism 
EDE1 YBL047C EPS15 endocytosis  
END3 YNL084C - endocytosis 
ENT1 YDL161W EPN3 endocytosis 
EXO70 YJL085W - cytokinesis 
EXO84 YBR102C EXOC8 exocytosis 
FUS1 YCL027W - conjugation with cellular fusion 
INP52 YNL106C SYNJ2 cell wall organization and biogenesis 
KEL1 YHR158C RABEPK cell morphogenesis 
LSG1 YGL099W GNL1 ribosome biogenesis 
MID2 YLR332W - cell wall organization and biogenesis 
PEA2 YER149C - pseudohyphal growth 
POP2 YNR052C CNOT8 
regulation of transcription from RNA 
polymerase II promoter 
SEC10 YLR166C EXOC5 
establishment of cell polarity (sensu 
Fungi) 
SEC18 YBR080C NSF ER to Golgi vesicle-mediated transport 
SEC2 YNL272C - exocytosis  
SEC3 YER008C - cytokinesis 
SEC5 YDR166C EXOC2 cytokinesis 
SEC6 YIL068C EXOC3 cytokinesis 
SEC8 YPR055W EXOC4 cytokinesis 
SHM2 YLR058C SHMT1 one-carbon compound metabolism  
SHR3 YDL212W - ER to Golgi vesicle-mediated transport 
SLA1 YBL007C GRAP cell wall organization and biogenesis 
SLG1 YOR008C - cell wall organization and biogenesis 
SMY1 YKL079W - exocytosis 
YCR043C YCR043C - biological process unknown  
YMR295C YMR295C - biological process unknown  
YOR304C-A YOR304C-A - biological process unknown  
* as calculated by InParanoid [12], listing only the top-scoring inparalog 
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TABLE 2.2: MANUALLY VERIFIED SHMOO TIP LOCALIZED PROTEINS IDENTIFIED BY 
THE CLASSIFIER.  As in [4]. 
Gene 
name ORF name 
Human 
ortholog* Gene Ontology biological process annotation 
ABP140 YOR239W METTL2B actin cytoskeleton organization and biogenesis  
ARK1 YNL020C AAK1 protein amino acid phosphorylation 
BCK1 YJL095W - protein amino acid phosphorylation 
BEM1 YBR200W - establishment of cell polarity (sensu Fungi) 
BNI1 YNL271C DIAPH1 pseudohyphal growth 
BOI1 YBL085W - establishment of cell polarity (sensu Fungi) 
BSP1 YPR171W - actin cortical patch distribution  
BUD6 YLR319C - actin filament organization 
BZZ1 YHR114W TRIP10 endocytosis 
CHS3 YBR023C - cytokinesis 
CHS5 YLR330W - spore wall assembly (sensu Fungi) 
ENT2 YLR206W EPN3 endocytosis 
KEL2 YGR238C RABEPK conjugation with cellular fusion 
LAS17 YOR181W WASL endocytosis 
MYO2 YOR326W MYO5B vesicle-mediated transport 
MYO5 YMR109W MYO1E cell wall organization and biogenesis 
PAN1 YIR006C - endocytosis 
PRK1 YIL095W AAK1 protein amino acid phosphorylation 
RGD1 YBR260C ARHGAP21 response to acid 
RVS161 YCR009C BIN3 endocytosis 
RVS167 YDR388W - endocytosis 
SAC6 YDR129C PLS3 endocytosis 
SEC15 YGL233W EXOC6 cytokinesis 
SEC31 YDL195W SEC31A ER to Golgi vesicle-mediated transport  
SFB3 YHR098C - ER to Golgi vesicle-mediated transport  
SHS1 YDL225W - establishment of cell polarity (sensu Fungi) 
SLA2 YNL243W HIP1R actin filament organization 
SMI1 YGR229C - regulation of fungal-type cell wall biogenesis 
SRV2 YNL138W CAP1 pseudohyphal growth 
SYP1 YCR030C - biological process unknown  
TWF1 YGR080W TWF1 bipolar bud site selection 
VRP1 YLR337C WIPF1 endocytosis 
WSC2 YNL283C - cell wall organization and biogenesis 
WSC3 YOL105C - cell wall organization and biogenesis 
YDR348C YDR348C - biological process unknown  
YER071C YER071C - biological process unknown 
YIR003W YIR003W - biological process unknown  
* as calculated by InParanoid [12], listing only the top-scoring inparalog 
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The classifier-guided retesting strategy doubled the coverage of the screen, and 
remaining false negatives could be rationalized based upon low protein abundance.  The 
targeted secondary screen had a much higher success rate than the initial unguided screen 
(1% vs. 31%).  Of the 37 genes identified in the second round of screening, 7 overlapped 
with previous literature, bringing the combined total of identified genes to 13 of 47 genes 
reported in the literature (Figure 2.2A).  Of genes in the GFP library, we could identify 
63% of the known shmoo tip-localized proteins that were present at >2500 
molecules/cell, but less than 21% of known proteins with <2500 molecules/cell, which 
suggest that the high false negative rate may primarily be due to the insensitivity of the 
microscope and camera.  On average, the shmoo tip proteins identified via the classifier 
method were less abundant than those recovered via the cell chip method, which suggests 
that using a network guided approach to expand an initial list of seed genes works well in 
cases with high false negative rates that can be reduced in lower-throughput assays.   
 
Adaptive re-use of polarization proteome 
Unsurprisingly, the set of 74 shmoo-localized proteins (37 each from initial screen 
and network identified), showed a marked enrichment for Gene Ontology functional 
categories related to polarized growth (with p < 10
-6
 being the threshold of probability 
calculated using a hypergeometric distribution [13] that the intersection of given list with 
any functional category occurs by chance), with the strongest enrichment observed for 
the GO Biological Process annotation establishment of cell polarity (p < 10
-35
), followed 
by annotations including anatomical structure morphogenesis (p < 10
-32
), cellular bud 
site selection (p < 10
-29
), cytokinetic process (p < 10
-28
), vesicle-mediated transport (p < 
10
-22
), reproduction (p < 10
-20
), endocytosis (p < 10
-18




), exocytosis (p < 10
-12
), and conjugation (p < 10
-6
).  Furthermore, there appears to be 
very broad reuse of the proteins during formation of the shmoo and buds (Figure 2.2B). 
 
In addition, 41 of the 74 proteins have human orthologs (Tables 2.1 & 2.2), 
which implies that there is a broad conservation of these processes across eukaryotes. 
 
Figure 2.3 indicates a number of complexes involved in the polarization process.  
The exocyst, an octomeric complex, helps dock vesicles to the bud site during cell 
growth.  Together, the initial and classifier screens identified all eight members of the 
complex, which strongly implies a conserved role for the complex in both budding and 
shmooing.  Members of the septin ring, a pentameric complex, were also identified, are 
characteristically present at the shmoo neck, forming a collar like structure.  One of the 
members CDC3, was absent from the GFP library and could not be identified.  
Additionally, several components of the actin cortical patch were identified as present in 
the shmoo, which illustrates the role of the actin cytoskeleton in supporting the polarized 
outgrowth.  Interestingly, we identified a number of genes which are actively involved in 
endocytosis, RVS161, RVS167, SAC6, and ENT2, which were broadly distributed 
throughout the shmoo, often in punctuates.  Figure 2.4 We observed that proteins 
involved in exocytosis were localize at the extreme tip of the shmoo while proteins 
involved in endocytosis localized more broadly around the shmoo tip, which may 




FIGURE 2.2  A. MANUAL VALIDATION BASED ON CLASSIFIER DOUBLES COVERAGE 
OF KNOWN SHMOO GENES.  B. GENES INVOLVED IN SHMOO FORMATION 
OVERLAP SIGNIFICANTLY WITH BUDDING GENES and indicate significant reuse 






FIGURE 2.3  IMAGES OF VARIOUS SHMOO LOCALIZED CELLULAR COMPONENTS.  





FIGURE 2.4  EXOCYTOTIC PROTEINS ARE MORE DISTALLY LOCATED THAN 
ENDOCYTOTIC PROTEINS IN THE SHMOO.  Adapted from [4]. 
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In addition to characterized complexes, the screen and network based classifier 
found several uncharacterized proteins, such as YMR295C [14], YDR348C, and 
YOR304C-A, localize to both the bud [10] and shmoo tips which implies general reuse in 
polarization. Examination of these proteins’ functional relationships in the yeast 
functional gene network illustrates their potential involvement in specific aspects of 
polarized cell growth (Figure 2.5): YOR304C-A is linked with Bud6, a key protein in 
polarization signaling (and also found in the screen) and Duo1, a cytoskeletal protein. 
YMR295C and YDR348C are network neighbors, with the former also linked to 
glycolytic transcription factor Gcr1, and the latter tied to the cell cycle progression genes 
Clb2 and Cdc28. Therefore, these genes may help connect polarization with other cellular 
systems such as cell cycle control and energy metabolism.  The functional network, 
therefore, helps predict the localization of uncharacterized genes and provides a starting 
point by which to evaluate their role. 
In line with the adaptive re-use of the polarization machinery, the primary 
predictive strength that prior localization data contributed to the classifier was bud 
localization.  However, only 6 of the 37 genes identified in the second round were bud 
localized, which suggests that the primary predictive power of the classifier came from 
the features derived from the functional network.  This demonstrates the power of the 
functional network to find likely false negatives from genome-wide screens of gene 




FIGURE 2.5  THE FUNCTIONAL NETWORK SUGGESTS POSSIBLE ROLES FOR 
UNKNOWN PROTEINS LOCALIZED TO THE SHMOO.  Characterized proteins are 
labeled in black and represented by yellow circles.  Uncharacterized proteins are 
in labeled in blue with red circles.  Bold genes are identified shmoo genes.  See 





Polarized growth is a fundamental cellular process that has been repurposed for 
multiple functions and the spatial distribution of the shmoo proteome demonstrates that a 
significant fraction of genes involved in polarized growth are shared by differing cellular 
processes in S. cerevisiae.  Of the 67 proteins shared between the mating and budding 
polarization processes (Figure 2.2) there is significantly greater conservation between 
human and yeast than expected by chance (39 of the 67 yeast genes have human 
orthologs [12], p < 0.023, chi-square test), suggesting that the functions of these core 
polarization components are consistent across eukaryotes.  Recognition of this significant 
overlap helps contribute to our understanding of phenologs, a topic I will be covering in 
detail in chapter 4. 
 
The functional network, which integrates a broad variety of data, but does not 
explicitly include location data, can predict protein localization even for uncharacterized 
genes.  Functional networks were developed to predict gene function [11] but this project 
illustrates that they are capable of broader application because they capture information 
beyond the originally intended application. 
 
The process of screening followed by prediction could be iterated by adding the 
newly identified shmoo genes to the training set.  This would then re-weight their 
neighboring genes in the network, which could potentially identify additional genes that 
are related to the shmoo and pheromone response pathways. 
 
This chapter has been abstracted and reworked from a paper that is in press [4]. 
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Chapter 3: Predicting yeast knockout phenotypes with a functional 
network 
INTRODUCTION 
After the successful application of the classifier to protein localization and expanding the 
coverage of genome wide screens, I looked for a related application where the network 
could guide research by providing targeted predictions.  I also sought to reduce the 
complexity and obscurity of the classifier by adopting a simpler, more broadly applicable, 
and intuitively understandable algorithm for prediction.  In this chapter and the associate 
paper [1], I demonstrate that loss-of-function yeast phenotypes are predictable by simple 
guilt-by-association in functional gene networks.  By computational testing of more than 
one thousand loss-of-function phenotypes from genome-wide assays of yeast I show that 
diverse phenotypes are predictable, spanning cellular morphology, growth, metabolism, 
and quantitative cell shape features.  I apply the method to (1) extend a genome-wide 
screen by predicting, then verifying, genes whose disruption elongates yeast cells, and (2) 
computationally predict human disease genes.  To facilitate network-guided screens, I 
have established a web server at http://www.yeastnet.org which provides network based 
predictions based on submitted genes.  
 
BACKGROUND 
Historically, genetic relationships between mutations were inferred when the mutations 
resulted in a shared phenotype.  Similar phenotypic outcomes were typically interpreted 
as representing a functional relationship between the two genes and these relationships 
were represented as genetic pathways and later as gene networks.  With high throughput 
technologies being integrated into functional networks, it is now possible to ask whether 
the inverse inference is possible.  Are functionally linked genes likely to share a common 
phenotype?  If so, it is possible to predict the phenotypic outcomes of gene disruption by 
extrapolating from known phenotypic data.  Of particular interest, the method could be 
applied to identify candidate genes that are likely to cause a specific disease when 
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mutated, based on their linkage to a known disease gene.  In this project, I show that a 
wide range of yeast phenotypes can be predicted using a functional network and 
demonstrate that the method is likely to be broadly applicable to human disease. 
 
Advances over the past decade in both forward and reverse genetics mean that the 
predictability I find can be applied in a simple way to correctly associate genes with 
phenotypes of interest.  For forward genetics, genome-wide association studies (reviewed 
in [2]) are starting to identify candidate genes associated with human traits and diseases, 
such as recent studies correlating variants in the ORMDL3 gene to risk of childhood 
asthma [3].  At the same time, reverse genetics by rapid testing of candidate genes has 
become more routine with the creation of mutant strain collections (e.g., yeast deletion 
strain collections [4, 5]) and the development of RNA interference (RNAi) for down-
regulation of genes (e.g., as for genome-wide RNAi screens of C. elegans [6, 7] or human 
cell lines, reviewed in [8]).  With the ability to predict loss-of-function phenotypes, I 
suggest utilizing the two aspects of genetics synergistically: with a starting set of genes 
linked to a specific phenotype by a forward genetic screen, computational predictions of 
additional genes associated with that phenotype can be evaluated using reverse genetics, 
expanding on the original screen, much like were able to do for shmoo localized proteins 
in the previous chapter.  Furthermore, given the polygenic nature of many diseases and 
phenotypes, this approach will improve the characterization of the network of genes 
affecting a trait of interest.   
 
Functional networks have been successfully used to annotate unknown genes using the 
principle of guilt-by-association (GBA), which assumes that the function of a gene is 
closely related to its neighbors in the network [9].  I applied GBA to predict yeast 
phenotypes using YeastNet v.2 [10] by asking if the genes linked to a seed set of genes 
associated with a particular loss-of-function phenotype might also be more likely to result 
in the same phenotype upon disruption.  This probabilistic functional gene network has 
102,803 functional links among 5,483 yeast genes, where the probability of a link 
indicates the likelihood that two genes will have the same Gene Ontology biological 
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process annotations [11] relative to the background expectation.  Genes are ordered by 
their connectivity to the initial set; the genes linked most strongly to the seed set become 
candidate genes for the same phenotype. 
 
An illustration of the functional network and GBA is displayed in Figure 3.1 as a graph 
with circles (genes) connected by edges (functional links).  Blue circles represent seed 
genes that lead to the target phenotype upon knockout.  Red circles represent tightly 
linked neighbors that are candidate genes that are predicted to give rise to the phenotype 
upon disruption.  The sums of the genes’ probabilistic linkages to the seed set are used to 
rank the phenotype predictions.  As a consequence, genes tightly linked to multiple seed 





FIGURE 3.1  OVERVIEW OF GUILT-BY-ASSOCIATION PHENOTYPE PREDICTION. Guilt-
by-association phenotype prediction employs a functional gene network, 
represented here as circles (genes) connected by lines (functional linkages), and a 
seed set of genes (blue circles) whose disruption is known to give rise to the 
phenotype of interest.  Neighboring genes in a functional gene network (red 
circles) are candidates for also giving rise to the phenotype.  Candidates are 
prioritized by the sum of their network linkage weights to the set of seed genes.  
A gene strongly linked to multiple seed genes will thus rank more highly than a 
gene weakly linked to a single seed gene.  Network drawn with Cytoscape [12].  





As published in [1]. 
Assembling the set of non-redundant loss-of-function phenotypes 
A literature search was conducted to find genome-scale studies of yeast gene 
knockout phenotypes.  Datasets were compiled from studies that systematically examined 
a large fraction of the yeast genome.  No effort was made to minimize redundancy among 
the gene sets themselves.  Nonetheless, only one set is a strict subset of another (genes 
that have changed levels of transposon cDNA upon knockout are a subset of the genes 
that reduce retrotransposition).  Most studies were conducted using one or more of the 
following strain collections: haploid [4], homozygous diploid [4], heterozygous diploid 
[4], tetracycline-titratable [13].  The reported data were a mix of qualitative, pseudo-
quantitative, and quantitative results.  Pseudo-quantitative data (often reported as "+", 
"++", "-", "--", etc.) were thresholded at the most stringent reported value (except for the 
small set of genes conferring the phenotype “branched cells” [4]; all genes with this 
morphology were included).  Quantitative data were arbitrarily thresholded using cutoffs 
that appeared consistent with the sensitivity of the assay.  Predictability was not used as a 
criterion for selecting thresholds.  In some cases, thresholds less stringent than those 
selected result in more predictable phenotype sets (data not shown).  In cases where an 
uncharacterized open reading frame overlapped a known gene on the chromosome and 
both shared the same phenotype (e.g. Axial budding [14]; the dubious open reading frame 
YOR300W overlaps BUD7), the uncharacterized gene was removed from the phenotype 
set.  Additional phenotypes were collected from the Saccharomyces Genome Database 
(SGD) [15]; phenotypes extracted from SGD used the threshold determined by SGD.   
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For the 281 quantitative phenotypes reported by SCMD [16], the 40 knockout 
strains with either the highest or lowest values for each SCMD feature were selected 
(resulting in 562 seed gene sets).  Similarly, 440 CV phenotypes were generated by 
considering the 40 knockout strains with either the higher or lowest CV for each SCMD 
CV feature (220 total features). 
 
Prediction of phenotypes and evaluation of prediction quality 
For each gene in the network, I calculated the sum of its link weights to genes 





iji LLSS , where j is a gene in the seed gene set, and LLSij is the log likelihood score 
for the linkage between gene i and gene j, as reported in [11] except where explicitly 
analyzing other networks.  Genes were then rank-ordered by their Si scores, with the 
highest scoring genes the most likely to share the phenotype with the seed set.  For 
networks reporting only binary linkages (MIPS [17], DIP [18]), I considered all linkages 
to be of weight 1.  For calculation of Figure 3.5, YeastNet v.2, DIP and PICO [19] were 
each evaluated at two different confidence levels.  For analyses of protein interaction 
networks, the following networks were analyzed:  YeastNet v. 2, which corresponds to all 
interactions reported in [11]; physical protein interactions (PPI) from the Database of 
Interacting Proteins (DIP) [18] (downloaded on February 4, 2007) selecting as the core 
set those interactions reported by [20];  Collins et al [21], using their reported threshold; 
PICO E-0 and E-2, PPI sets from [19]; MIPS, all PPI in physical complexes reported by 
[19] derived from [17].  In all cases, self interactions were removed. 
 
For each phenotype, the predictability was evaluated by generating a ROC curve 
based upon the gene ranking and calculating the area under the curve (AUC).  The ROC 
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curve indicates the relative rate of true and false positive predictions as a function of the 
score Si, plotting the true positive rate (TP/(TP+FN)) versus false positive rate 
(FP/(FP+TN)).  In calculating Si, self-self links were not permitted, and each gene in the 
seed set was withheld in turn from the seed set for evaluation (i.e., leave-one-out cross-
validation).  TP, true positives, was defined (for a specific threshold) as the number of 
genes from the seed set ranked above a given Si; FP, false positives, as the number of 
genes above the threshold but not in the seed set; FN, false negatives, as the number of 
seed genes ranked below the threshold; and TN, true negatives, as the number of non-
seed genes ranked below the threshold.  The AUC ranges from 0 to 1, with 0.5 indicating 
random performance and 1.0 indicating perfect classification.  Note that AUC is 
calculated using only seed genes represented in the network (i.e., the network is not 
penalized for partial coverage of the seed set), allowing the predictive capacity of 
networks of differing sizes to be compared.  For the purposes of calculating a ROC curve, 
all genes not linked to the phenotype seed set were treated as being of the same rank.  
Note that none of the phenotypes have been tested for all genes (most tested only non-
essential genes).  Due to differences in the reporting of genes tested, ROC curves for the 
set of 100 phenotypes were calculated over the entire set of yeast genes in the network 
being tested (5,483 genes for the functional network).  Thus, the measures of 
predictability (AUC) are likely to be underestimates, since all untested genes are 
considered false positives. 
 
As an alternative test for functional enrichment, I used ArrayPlex [22] to calculate 
the hypergeometric probability of the enrichment for each GO annotation within a given 
gene set. 
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Prediction of human disease gene sets 
For the test of human disease gene prediction, I collected sets of yeast genes 
whose human orthologs were linked to the same OMIM disease [23].  Human disease 
phenotypes from OMIM were collapsed into major categories (i.e., variants of each 
disease were collapsed into a single category, such as collapsing “Cataract, polymorphic 
and lamellar” and “Cataract, crystalline aculeiform” into a single category of cataract 
defects).  Each human disease gene was mapped to one of 2,151 human-yeast orthology 
groups using InParanoid [24], and seed sets of yeast genes linked to the same disease 
were selected such that at least 4 of the yeast genes were present in YeastNet.  
Calculation of predictability and measurement of AUC was performed as for yeast 
phenotypes, considering linkages in YeastNet between human-yeast orthology groups 
rather than between individual yeast genes. 
Generation of random phenotype sets 
In order to estimate the random distribution of AUC scores for literature 
phenotypes, sets of genes of the same sizes as the real phenotype seed sets were drawn 
from the complete set of yeast genes and tested for predictability, using as the 
background set of genes those designated by SGD as "verified" or "uncharacterized" (not 
dubious or pseudogenes) (as of January 29, 2007).  For SCMD morphology phenotypes 
[16], 1000 sets of 40 genes were drawn randomly from the complete set of genes 
analyzed by SCMD, then tested for predictability in order to generate the null expectation 
for the AUC distribution.  For human disease phenotypes, random gene sets were 
generated for comparison by randomly drawing from the set of network annotated 
human-yeast orthologs such that the set size distribution of the random sets matched the 
size distribution of the actual OMIM disease seed sets. 
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Yeast strains, media, and growth 
For predicting elongation mutants, I employed a seed set of 77 non-essential 
genes identified by Giaever et al. [4] as “Elongate 3” in a screen of the homozygous 
diploid yeast deletion collection.  Using GBA with this seed set, I predicted additional 
genes likely to give rise to elongated cells, and selected for assay the 35 top-ranked 
essential genes with strains available in the tetracycline-downregulatable library of yeast 
strains [13].  A negative set of 17 strains from the same library was randomly selected 
from those genes not linked to any of the known elongated genes.  The corresponding 
strains were obtained from Open Biosystems.  Each strain was grown to saturation at 
30°C in YPD, inoculated into fresh YPD with 10 ng/ml doxycycline, grown 16 hours and 
imaged [13] to evaluate cell morphology.  Two biologists evaluated the images for each 
strain (with strain names hidden) for elongated cell morphologies using a simple 
qualitative scoring scheme (0-2), assigning a final score to each strain as the sum of the 
independent evaluations.  Strains scoring >2 were selected as elongated, which 
minimized false positives, yet recovered NUT2, previously reported to be elongated 
[13].   Wei Niu helped train me in microscopy and helped handle the yeast library.  
Edward Marcotte helped with image analysis. 
 
In order to predict gene-phenotype associations (see prediction testing below for 
phenotypes tested), I calculated the sum of links between a given gene and a seed set of 
genes known to lead to a specific phenotype upon knockout, i.e., each gene in the 




iji LLSS , where j is a gene with the given 
phenotype, and LLSij is the log likelihood score for the linkage between gene i and gene j.  
Self-self links were not permitted, effectively making the approach equivalent to a 
classifier using leave-one-out cross-validation.  The genes with the highest Si score are 
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most likely to share the phenotype with the seed set.  Genes were rank ordered by their Si 
score for each phenotype, which was used to generate a ROC curve and calculate the area 
under the curve (AUC).  The ROC curve plots the relative true positive rate 
(TP/(TP+FN)) to the false positive rate (FP/(FP+TN)) as a function of Si.  True positives, 
TP, were defined (for a given Si threshold) as the number of genes with the specific 
phenotype that scored above the threshold; false positives, FP, as the number of 
phenotype related genes below the threshold; false negatives, FN, as the number of genes 
in the set below the threshold; and true negatives, TN, as the number of genes not known 
to have the phenotype below the threshold.  The AUC can range from 0 to 1, with 0.5 
indicating that the predictions are random.  The appropriate background set of genes 
varies between phenotype screens, since none of the knockout libraries are complete; 
however, the ROC curves were calculated assuming that the entire genome has been 
screened.  It is likely that the real AUC is underestimated for many phenotypes, since 
untested, predicted genes are treated as false positives. 
 
RESULTS 
To evaluate the utility of applying the GBA concept to phenotype prediction, I 
initially tested predictions computationally with a large assortment of phenotypes and 
then experimentally validated a set of predictions for a specific morphological trait. 
Computational Results 
Using Guilt-By-Association to Predict Essentiality 
I first investigated whether the network could distinguish viable from non-viable 
yeast gene deletion strains.  Essential genes of both yeast and humans are known to be 
more highly connected in protein physical interaction networks than non-essential genes 
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[25-27], and there is evidence that essential proteins may also be enriched in the same 
physical complexes [19, 28].  I asked if essential genes could be predicted on the basis of 
their connections to other essential genes in a functional gene network.  I employed the 
guilt-by-association approach, using as the seed set the 1,027 known essential yeast genes 
[4, 29], then scoring each gene in yeast for its likelihood to be essential as a function of 
connectivity to this seed set.  As described in the methods above, each gene in the seed 
set was withheld in turn from the seed set in order to evaluate it; i.e., performing leave-
one-out cross-validation.  As the prediction score for each gene, I calculated the sum of 
the weights of linkages connecting the query gene to genes in the seed set.  Given that 
each linkage’s weight in this network corresponds to the log likelihood of the linked 
genes belonging to the same pathway [11] the sum of linkage weights therefore 
represents the naïve Bayesian combination of evidence that the query gene belongs to the 
same pathway as the seed set genes.  I expect genes in the same pathway to often exhibit 
the same loss-of-function phenotypes.  Thus, this score should also serve to identify 
genes that share phenotypes with the seed set genes. 
 
To evaluate prediction quality, I calculated the true positive rate (sensitivity, 
TP/(TP+FN)) and the false positive rate (1-specificity, FP/(FP+TN)), as a function of the 
prediction score, plotting the resulting receiver operating characteristic (ROC) curve.  As 
Figure 3.2 shows, the essential genes are strongly predictable on the basis of their 
network neighbors.  Therefore, in addition to the previous observations that essential 
genes have larger numbers of physical interaction partners, I demonstrate that essential 
yeast genes are also preferentially connected to each other in a functional network.  
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A yeast gene network predicts varied, specific loss-of-function phenotypes 
In order to further test phenotypic predictability, I collected an additional set of 99 
yeast knockout phenotypes that had been generated in large scale genetic screens that 
assayed a substantial fraction of the genome (typically, all non-essential genes).  These 
reverse genetic screens are made possible by the recent creation of libraries of yeast 
knockout strains [4, 5] and are reported either in the Saccharomyces Genome Database 
(SGD; [30]) or in one of 32 additional publications in the literature, listed in full in Table 
3.1.  In these collections, a single yeast gene is deleted in each yeast strain; a phenotypic 
assay on the complete set of knockout strains thereby associates that phenotype with 
those deleted genes that gave rise to it.  These screens are ideal for addressing the general 
question of whether or not specific loss-of-function phenotypes are predictable.  
Crucially, the phenotypic data is not integrated into the functional network [11], which 




FIGURE 3.2  DIVERSE YEAST GENE LOSS-OF-FUNCTION PHENOTYPES ARE 
PREDICTABLE USING GUILT-BY-ASSOCIATION IN A FUNCTIONAL GENE 
NETWORK.  Predictability is measured in a ROC plot of the true positive rate 
(sensitivity) versus false positive rate (1-specificity) for predicting genes giving 
rise to 10 specific loss-of-function phenotypes, as well as for essential genes 
whose disruption produces nonviable yeast [4].  For each phenotype, each gene in 
the yeast genome was prioritized by the sum of the weights of its network 
linkages to the seed genes associated with the phenotype.  Genes with higher 
scores are more tightly linked to the seed set and therefore more likely to give rise 
to the phenotype. Each phenotype was evaluated using leave-one-out cross-
validation, omitting genes from the seed set for the purposes of evaluation. More 
predictable phenotypes tend towards the top-left corner of the graph; random 
predictability is indicated by the diagonal.  For clarity, the line connecting the 
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final point of each graph to the top right corner has been omitted.  Figure used by 
permission [1]. 
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TABLE 3.1.  PREDICTABILITY OF 100 YEAST GENE DELETION PHENOTYPES.  Table 
used by permission from [1]. 
 








caspofungin sensitive 0.996 20 18 [31] 
increased resistance to calcofluor white  0.982 10 10 [32] 
unipolar budding 0.941 10 10 [14] 
CPY secretion (3) 0.937 46 44 [33] 
cell cycle arrest defective 0.930 8 8 [34] 
UVC sensitive (high) 0.919 15 14 [35] 
sensitivity at 15 generations in galactose  0.908 17 14 [4] 
CANR mutator (high) 0.904 18 18 [36] 
haploinsufficient in rich medium (YPD) 0.898 184 184 [37] 
cellular chitin level increased (3) 0.873 22 21 [32] 
bleomycin resistant (3) 0.871 5 4 [38] 
morphology: branched (diploid) 0.870 5 5 [4] 
sensitivity at 15 generations in 1.5 M sorbitol  0.867 6 4 [4] 
caspofungin resistant 0.866 8 8 [31] 
inviable (essential) 0.845 1100 1027 [4, 
29] 
shortened telomeres (3) 0.843 20 18 [39] 
sensitivity at 15 generations in minimal +his 
+leu +ura medium 
0.843 77 70 [4] 
MMS sensitive (3) 0.837 78 73 [40] 
cellular chitin level reduced (2) 0.835 17 17 [32] 
Petite 0.833 179 166 [41] 
sensitivity at 5 generations in minimal +his 
+leu +ura medium 
0.827 62 51 [4] 
long telomeres (3) 0.824 6 6 [39] 
decreased calcofluor white resistance 0.814 65 63 [37, 
42] 
Growth defect on a fermentable carbon source  0.812 257 249 [43] 
transposon cDNA expression changed (high) 0.810 27 26 [44] 
morphology: clumpy (3)(diploid) 0.802 18 18 [4] 
gamma radiation sensitive (3) 0.793 31 31 [45] 
cell cycle arrest defective and defective shmoo 0.782 30 29 [34] 
sensitivity at 5 generations in galactose  0.781 11 10 [4] 
small (haploid) 0.778 215 192 [46] 
retrotransposition reduced 0.772 99 89 [44] 
K1 killer toxin sensitive (40%) 0.770 72 72 [42] 
increased iron uptake 0.757 76 70 [47] 
Growth defect on a non-fermentable carbon 
source  
0.755 498 448 [43] 
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gentamycin sensitive (high) 0.754 11 11 [48] 
proteasome inhibitor sens (high) 0.753 22 22 [49] 
reduced fitness in rich medium (YPD) 0.748 891 872 [37] 
mycophenolic acid sensitive 0.746 38 33 [50] 
axial budding 0.745 4 4 [14] 
morphology: elongate (3) (diploid) 0.739 77 73 [4] 
sporulation deficient 0.738 261 244 [51] 
random budding (high) 0.737 74 72 [14] 
large (haploid) 0.728 227 205 [46] 
reduced sporulation (3) (normal respiration) 0.722 136 119 [52] 
bleomycin sensitive (4) 0.721 58 55 [38] 
sensitivity at 5 generations in synthetic 
complete - lys medium 
0.715 23 22 [4] 
decreased rapamycin resistance 0.707 272 256 [53] 
whi 0.706 19 19 [41] 
sensitivity at 5 generations in 1.5 M sorbitol  0.704 13 11 [4] 
decreased wortmannin resistance 0.703 89 85 [53] 
sensitivity at 20 generations in 1 M NaCl  0.703 63 59 [4] 
K1 killer toxin resistant (40%) 0.698 19 18 [42] 
morphology: round (3) (diploid) 0.696 105 99 [4] 
uge 0.694 28 26 [41] 
sensitivity at 5 generations in synthetic 
complete - trp medium 
0.694 48 45 [4] 
sensitivity at 5 generations in 1 M NaCl  0.693 60 56 [4] 
rapamycin resist (2) 0.692 26 26 [54] 
reduced iron uptake 0.688 5 5 [47] 
rate of growth loss of growth in 0.85 M NaCl 0.682 212 189 [55] 
sensitivity at 5 generations in medium of pH 8  0.677 102 93 [4] 
sensitivity at 15 generations in medium of pH 8  0.676 128 115 [4] 
morphology: small (3)(diploid) 0.672 79 69 [4] 
sensitivity at 15 generations in 10 uM nystatin  0.672 28 27 [4] 
morphology: large (3)(diploid) 0.669 88 80 [4] 
reduced glycogen storage (2) 0.666 44 41 [56] 
sensitivity at 5 generations in 10 uM nystatin  0.666 124 108 [4] 
increased rapamycin resistance   0.662 114 100 [53] 
morphology: unusual shmoo (haploid) 0.661 29 25 [34] 
morphology: polarized bud growth (haploid) 0.657 5 5 [34] 
wortmannin resistant (5) 0.656 25 23 [57] 
sensitivity at 5 generations in synthetic 
complete - thr medium 
0.647 31 29 [4] 
enhanced glycogen storage (2) 0.645 61 55 [56] 
proteasome inhibitor resistant 0.642 7 6 [49] 
reduced spores per ascus 0.641 37 34 [52] 
rate of growth sensitivity in 0.85 M NaCl 0.629 209 191 [55] 
morphology: football (3) (diploid) 0.628 59 53 [4] 
germination deficient 0.627 158 147 [51] 
sporulation promoting 0.622 102 98 [51] 
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6AU sensitive (3) 0.618 28 26 [58] 
increased wortmannin resistance 0.617 80 75 [53] 
morphology: elongated (haploid) 0.603 110 101 [34] 
rapamycin sensitive (4) 0.597 20 20 [54] 
efficiency of growth sensitivity in 0.85 M NaCl 0.597 65 58 [55] 
decreased rapamycin resistance 0.597 8 7 [53] 
slow growth in YPD (16x below WT) 0.585 23 22 [4] 
MPA sensitive (3) 0.563 24 22 [58] 
morphology: round (haploid) 0.552 13 11 [34] 
efficiency of growth resistance in 0.85 M NaCl 0.541 44 40 [55] 
sensitivity at 5 generations in synthetic 
complete medium 
0.531 88 78 [4] 
morphology: large (haploid) 0.527 23 21 [34] 
adaptation time loss of growth in 0.85 M NaCl 0.526 103 91 [55] 
adaptation time sensitivity in 0.85 M NaCl 0.521 284 259 [55] 
decreased sensitivity to the anticancer drug, 
cisplatin 
0.512 22 19 [59] 
morphology: chain (diploid) 0.485 5 5 [4] 
morphology: small (haploid) 0.480 94 89 [34] 
rate of growth resistance in 0.85 M NaCl 0.479 59 49 [55] 
morphology: clumped (haploid) 0.479 32 28 [34] 
adaptation time resistance in 0.85 M NaCl 0.465 69 60 [55] 
efficiency of growth loss of growth in 0.85 M 
NaCl 
0.464 23 21 [55] 
morphology: pointed (haploid) 0.453 99 88 [34] 
a
Numbers in parentheses indicate threshold applied to generate seed set, e.g., (3) indicates ‘+++’ 
or ‘---’, as appropriate. 
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Each phenotype was evaluated for the area under the ROC curve (a measure of 
predictability), as described in the methods.  Specifically, I used hits from these screens 
as seed sets for predicting the associated phenotypes from the yeast network, performing 
leave-one-out cross-validation, just as for the prediction of essential genes.  The 
network’s predictive power for a representative assortment of these phenotypes is 
displayed in Figure 3.2.  In order to evaluate the overall trends in these data, I calculated 
the area under each of the 100 ROC curves (AUC) as a measure of prediction strength—
an AUC value of 0.5 indicates random performance, while an AUC value of 1.0 indicates 
perfect predictions.  I found that a majority of phenotypes are reasonably predictable 
(Figure 3.3), with 70% of the phenotypes predictable at AUC > 0.65.  In contrast, none 
of 100 random gene sets of the same sizes as the actual phenotypic seed sets exhibited 
AUC > 0.65.  The AUC of the highest scoring random set was 0.64, which indicates that 
phenotypes with AUC > 0.65 were significant to at least p < 0.01.  In order to contrast the 
AUC of real phenotypes derived from the literature with what would be expected under a 
random distribution, I generated equivalent sets of random genes by drawing from the 
complete set genes labeled by SGD [15] as verified or uncharacterized (as of January 29, 
2007).  The random sets were size matched to the real phenotype sets. 
 
A wide range of phenotypes are highly predictable, including: shortened 
telomeres [39], increased secretion of CPY protein [33] (an indicator of disruption of 
sorting in the secretory system), and chitin accumulation [32].  Many categories of 
phenotype are at least moderately predictable, including both very specific phenotypes, 
such as iron uptake [47] and caspofungin sensitivity [31], and broader phenotypes like 
gross cellular morphology (small cells [46], round cells [4], etc.).  Surprisingly, there is 
little dependence of predictability on the size of the seed set (Figure 3.4), and I observed 
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strong predictability for both large and small seed sets (e.g., bleomycin resistance [38], n 





FIGURE 3.3  LOSS-OF-FUNCTION PHENOTYPES ARE PREDICTED SIGNIFICANTLY 
BETTER THAN RANDOM EXPECTATION.  Here, predictability is measured as the 
area under a ROC curve (AUC), measuring the AUC for each of 100 yeast 
phenotypes observed in genome-wide screens and plotting the resulting AUC 
distributions.  Real phenotypes are significantly more predictable than size-
matched random gene sets.  At the left of each box-and-whisker plot, the center of 
the blue diamond indicates the AUC mean, the top and bottom of the diamond 
indicate the 95% confidence interval, and the accompanying solid vertical line 
indicates +/- 2 standard deviations.  The bottom, middle, and top horizontal lines 
of the box-and-whisker plots represent the 1st quartile, the median, and the 3rd 
quartile of AUCs, respectively; whiskers indicate 1.5 times the interquartile range.  





FIGURE 3.4  A PLOT OF SEED SET SIZE VERSUS PREDICTABILITY OF THE PHENOTYPE 
SHOWS NO SIGNIFICANT CORRELATION.  Thus, there does not appear to be an 
intrinsic limitation for applying network-guided reverse genetics even when seed 
set size is small.  Each filled circle indicates the prediction strength (AUC, as 
calculated in Figure 3.3) of one of the 100 loss-of-function phenotypes relative to 




Integration of functional genomics and proteomics data is important for phenotype 
prediction 
As physically interacting proteins often share related genetic interaction partners 
(e.g., [60, 61]) and even human disease associations [25, 62, 63], it seemed likely that 
physical protein interactions might account for a large fraction of the signal I observe.  In 
particular, Lage et al [62] has used guilt-by-association among protein complexes to 
predict disease genes within human genetic linkage groups.  Balancing this trend, 
phenotypes of annotated genes are in part predictable directly from the annotations [64].  
Thus, I asked if the integration of functional genomics and proteomics data in the 
functional network brought additional predictive power over physical interactions alone.  
To compare the predictive accuracy of the functional network to protein interaction 
networks, I repeated the GBA analysis with several protein interaction networks [17-19, 
21].  I used any weightings reported with the interactions and weighted all interactions 
equally in the absence of a reported interaction probability.  I measured the median AUC 
across the same 100 phenotypes discussed above for the functional yeast gene network 
and for each of several versions of the yeast protein physical interaction network [17-19, 
21].  I compared these values to the median fraction of each seed gene set covered by the 
respective networks.  The values of AUC and fraction covered therefore serve as 
measures of precision and recall for each network.  As Figure 3.5 demonstrates, I 
observe that all networks predict loss-of-function phenotypes to some extent, but find the 





FIGURE 3.5  FUNCTIONAL NETWORKS HAVE GREATER PREDICTIVE POWER FOR 
PHENOTYPE THAN PHYSICAL PROTEIN NETWORKS.  Median values of 
predictive power (AUC) across 100 loss-of-function phenotypes are plotted 
versus the median fraction of each seed gene set covered by a network (coverage; 
measured as the fraction of seed genes with at least one linkage in the network).  
Five networks are compared: the functional yeast network (YeastNet v. 2 [11]) 
and four versions of the network of yeast physical protein interactions (DIP [18], 
PICO [19], MIPS physical complexes [17], and Collins et al. [21]).  DIP, PICO, 
and YeastNet are each evaluated at their two reported confidence thresholds.  The 
YeastNet functional gene network shows considerably higher predictive power 
than for the networks composed only of physical interactions; the full YeastNet 
shows higher predictive power than a more confident core set of the top 47,000 
linkages, indicating that the lower confidence linkages nonetheless add predictive 




I attribute this enhanced performance to the increased comprehensiveness of the 
functional gene network, both in terms of additional types of gene associations as well as 
more extensive coverage of the overall set of yeast genes.  The functional network 
accomplishes this by incorporating other sources of functional interaction (e.g., mRNA 
co-expression) in addition to physical interactions from both small scale (e.g., the DIP 
and MIPS databases) and genome scale (e.g., mass spectrometry of affinity-purified 
protein complexes and yeast two hybrid) experiments.  Figure 3.6 illustrates two sub-
networks that contribute to the prediction of two difference phenotypes, one of which 
depends heavily on the physical interaction data (A), but the other does not (B).  This 
suggests that many phenotypes are the result of more than the disruption of protein 
complexes or interactions.  The integration of many types of data, including protein 
interactions, allows the functional network to predict phenotypes regardless of the 
underlying mechanism that leads to the phenotype.  This is a clear example that 
integration of multiple types of functional data improves the predictive accuracy and gene 
coverage of the functional network over the underlying datasets. 
 
Further, as shown in Figure 3.7, the sequential addition of progressively lower 
confidence functional linkages increases both predictive accuracy and coverage. Low 
confidence linkages do not undercut the predictive power of high confidence linkages 
because they are weighted in proportion to the strength of the evidence that supports 
them. These observations highlight the importance of integrating diverse data types 
within a consistent statistical frame work and suggest that the proteins encoded by genes 
associated with the same phenotype often may not physically interact.  As additional 
functional data are collected by the scientific community, they can be quickly integrated 
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within the network framework to generate more accurate functional networks, and, as 





FIGURE 3.6  PREDICTIVE POWER OF FUNCTIONAL NETWORK RELIES ON PHYSICAL 
AND FUNCTIONAL INFORMATION.  (A) and (B) show example seed gene sets 
(green circles) and their network connections, indicating functional linkages in 
grey lines, physical interactions in thin black lines, and both functional and 
physical interactions in thick black lines.  (A) shows genes whose deletion 
increases cellular chitin levels [32] (AUC = 0.87), whose prediction relies upon a 
mix of physical and functional interactions.  (B) shows genes whose deletion 
confers sensitivity at 5 generations in synthetic complete medium lacking 
threonine [4] (AUC = 0.65), whose prediction derives predominantly from 






FIGURE 3.7  LOWER PROBABILITY LINKAGES CONTINUE TO IMPROVE PREDICTIVE 
ACCURACY, ALBEIT WITH DIMINISHING RETURNS, shown in a plot of the 
predictive accuracy (median AUC across the 100 phenotypes, calculated as in 
Figure 3.3) versus median network coverage of the 100 phenotype sets, as 
calculated for the top-ranked 20000 (20K), 40000 (40K), etc. linkages in 
YeastNet v.2.  This trend derives from the fact that all links in this network have 
at least a 60% probability of linking genes in the same pathway.  The probabilistic 
nature of the network means that low confidence linkages are unlikely to undercut 
high confidence linkages during phenotype prediction because the links are 
weighted according to the strength of the evidence supporting them.  Error bars 




FIGURE 3.8  ITERATIONS OF THE FUNCTIONAL NETWORK IMPROVE PHENOTYPE 
PREDICTION.  Additional data integrated into the functional network improves 
phenotype prediction over time, with new links improving both predictive 
accuracy and coverage of genes with known phenotypes.  YeastNet1 [9], 
YeastNet2 [11], and YeastNet3 [65] use the same basic approach to integrate data, 




Prediction of quantitative cell morphology phenotypes 
Having established the predictive power of the network for largely qualitative 
phenotypes, I chose to I apply the same approach to the quantitative, morphological 
phenotypes.  Given that the phenotypes analyzed thus far are often based on subjective 
criteria (i.e., judged to be elongated or not), it is important to ask if such predictions can 
be made for quantitative phenotypes.  So, I tested the predictive power of the GBA 
approach on quantitative cell morphology data reported by the Saccharomyces cerevisiae 
morphology database (SCMD) [16], which were systematically measured for the set of 
haploid MATa yeast deletion strains [66].  281 quantitative features of cell shape, 
cellular, and subcellular morphology were measured for each strain, including such 
parameters as the ratio of long cell axis to short cell axis, the angle between a mother cell 
and bud, and the relative distribution of actin with regards to the bud position.  Each 
feature was measured for many cells from a given strain, and the mean value reported.  
For 220 of the features, the coefficient of variance (CV) was also reported, describing the 
variability in that feature across single cells in that strain.  Considering the mean value of 
each feature and the CV as separate traits (the former will be referred to as morphology 
phenotypes and the latter as CV phenotypes) means that a total of 501 cell shape 
measurements or CVs were reported for 4,718 strains. 
 
As not all measurable cell shape features are likely to be under selection (for 
example, they might simply vary stochastically yet neutrally), I do not expect all such 
phenotypes to correspond to functional pathways and therefore be predictable.  
Nonetheless, one might expect that a number of these would have functional correlates 
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and therefore be predictable.  In order to test this notion, I therefore evaluated each of the 
501 features for predictability using the functional gene network. 
  
To generate seed gene sets from these data, for each of the 281 quantitative 
features I selected as phenotypic seed sets the 40 genes with the highest measured mean 
value of that feature and the 40 genes with the lowest measured mean value of that 
feature, in all generating 562 morphology phenotype seed gene sets (281 features x 2 
seed sets each).  I then evaluated each of these seed sets for predictability using ROC 
analysis.  As for the 100 genome-wide phenotypic screens, I observed many strongly 
predictable cell morphology phenotypes, such as those illustrated in Figure 3.9.  For 
example, one of the most strongly predictable cell morphology phenotypes is for the 
genes whose disruption most increases cell ellipticity during nuclear migration to the bud 
neck (AUC = 0.87).  Another strongly predictable phenotype is for deletion strains 
showing the highest increase in the actin polarization of unbudded cells (AUC = 0.80). 
 
The AUC distribution of 562 quantitative phenotypes from SCMD is compared to 
the background random distribution in the next figure (Figure 3.10).  Although many 
morphological phenotypes overlap with the random distribution, a significant portion of 
the phenotypes are more predictable than explainable by chance.  For the SCMD 
phenotype sets, the model for random expectation was generated by drawing 1000 sets of 
40 genes from the set of genes SMCD analyzed and calculating the AUC for each 
random set.  Note that predictability does not depend strongly on the size of the seed sets; 
I see similar predictive power with seed sets of 10 - 80 genes (data not shown).  These 
results confirm that even specific quantitative aspects of yeast cell shape often have 
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functional correlates, and therefore the sets of genes whose disruption most affects such 




FIGURE 3.9  NETWORK-BASED PREDICTIONS OF QUANTITATIVE CELL MORPHOLOGY 
PHENOTYPES.  A WIDE VARIETY OF PHENOTYPES BASED UPON 
QUANTITATIVE YEAST CELL SHAPE AND INTRACELLULAR FEATURES ARE 
PREDICTABLE [66], as shown for the 10 phenotypes in this ROC analysis 
(selected from SCMD phenotypes with AUC > 0.68).  For each of the features, 
the 40 genes whose deletion mutants show either the 40 highest or 40 lowest 
values for that quantitative feature (indicated by “high” or “low”, respectively) 
were selected as the seed gene set.  Predictability was evaluated using ROC 
analysis as in Figure 2, plotting the true positive prediction rate versus false 
positive rate, using leave-one-out cross-validation.  For clarity, the line 
connecting the final point of each graph to the top right corner has been omitted.  
Labels of features are adapted for clarity from the Saccharomyces cerevisiae 
Morphology Database [16]; the SCMD labels A, A1B, and C, represent unbudded 
cells, budded cell with one nucleus in mother cell, and large-budded post-mitotic 
cells with nuclei in both mother and daughter cell, respectively.  Ratio 





FIGURE 3.10  PREDICTIONS OF QUANTITATIVE CELL MORPHOLOGY PHENOTYPES 
ARE SIGNIFICANTLY BETTER THAN RANDOM. A histogram plotting the 
distribution of the AUC values for 562 quantitative morphological phenotypes 
shows a significantly higher proportion of high AUC values than for 1,000 size-
matched random gene sets.  Figure used by permission [1]. 
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Genes increasing cell-to-cell variation are less functionally coherent than those 
decreasing variation 
With two types of quantitative traits in SCMD, the traits themselves and their 
variance, I decided to see if subsets of the phenotypes were differentially predictable.  
Specifically, I asked if the coefficient of variance of a yeast morphology phenotype 
across single cells in a population was itself a predictable phenotype.  Strikingly, I 
observed good predictability for sets of genes whose disruption most increased the CV of 
a given morphological feature (e.g., the 40 genes whose deletion caused the highest 
increase in bud neck width CV; AUC = 0.70), but near random prediction for sets of 
genes whose disruption most decreased the CV in a given morphological feature (e.g., 
the 40 genes whose deletion most reduced bud neck width CV; AUC = 0.54) (Figure 
3.11).  The high CV phenotypes are significantly more predictable than the low CV 
phenotypes (p < 0.0001, Wilcoxon signed-ranks test).  Across the 220 high CV 
phenotypes, I observed 116 to show significantly greater AUC values than size-matched 
random sets (at the 95% confidence level as judged by Z-score > 1.95), while only 26 of 
the set of 220 low CV phenotypes were better than random at this level. 
 
Upon further analysis, it became clear that while quantitative, morphological 
phenotypes were predictable at both the high and low ends of the measured distribution, 
only high, but not low, coefficient-of-variance phenotypes are predictable.  As successful 
prediction of a loss-of-function phenotype implies functional coherence of the genes—
essentially reflecting clustering of the genes in the functional network—this result 
indicates that the genes whose disruption most strongly reduced the CV in a given 
morphological feature do not in general form a functionally coherent set.  By contrast, 
genes whose disruption most increased morphological phenotypic variability were 
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predictable, and thus functionally coherent.  I further observed that the same genes tended 
to be present in the phenotypic sets from many different CV phenotypes—i.e., there are 
particular genes whose deletion increases the coefficient of variance of a large number of 




FIGURE 3.11  GENES WHOSE DISRUPTION DECREASES POPULATION CO-EFFICIENT 
OF VARIANCE (CV) ARE ESSENTIALLY RANDOM.  Separate analyses of 
phenotypes associated with morphological features and phenotypes associated 
with cell-to-cell variability in the morphological features reveals asymmetry in 
predictability. Sets of genes whose disruption causes the 40 largest or smallest 
mean values of a morphological feature (middle plots) are significantly more 
predictable than random gene sets (left side).  By contrast, while the sets of genes 
whose disruption most increase the CV tend to be predictable (high AUC), those 
that most decrease the CV are not (low AUC).  Box-and-whisker plots are drawn 




To further explore this observation, for each of the 4,718 yeast genes in the SCMD data 
set, I calculated the median percentile rank across each of the 220 SCMD CV 
phenotypes.  Thus, the gene whose deletion strain has the highest median percentile rank 
(the telomere length regulation gene EST1; median percentile rank of 0.98) exhibits the 
highest cell-to-cell variability across nearly all of the set of 220 CV phenotypes.  By 
contrast, the gene whose deletion strain has the lowest median percentile rank 
(YAL004W, a small open reading frame that overlaps the coding sequence for the HSP70 
family chaperone SSA1; median percentile rank 0.17) consistently exhibits the lowest 
cell-to-cell variability for the tested phenotypes.  Thus, these rankings capture the generic 
tendency for a gene to increase or decrease cell-to-cell variability across many measured 
morphology parameters.  I tested the top-ranked 40 genes and the bottom-ranked 40 
genes for their network-based predictability.   
 
As with my earlier observations, the top-ranked 40 genes (those with highest 
median percentile rank) show reasonable predictability (AUC = 0.71), while the bottom-
ranked 40 genes show random predictability (AUC = 0.49).  Thus, either on a phenotype-
by-phenotype basis, or across all 220 phenotypes, genes whose disruption most increased 
morphological phenotypic variability tended to be more predictable and functionally 
coherent than those that reduced phenotypic variability.  By comparing the distribution of 
the median percentile rank of all 220 coefficient of variance phenotypes for each of the 
4,718 knockout strain to 127 wild-type replicates, I were able to identify a cluster of 
genes involved in DNA repair that consistently lead to higher coefficients of variance for 
many phenotypes (Figure 3.12).  The top-ranked set of 40 genes show strong enrichment 
for specific Gene Ontology terms, with 17 of the 40 genes encoding nuclear proteins (p < 
10
-6




including genes of DNA recombination and repair (p < 10
-6
).  Many of these genes are 
involved in maintaining genomic stability, including the repair/recombination proteins 
RAD27, RAD50, RAD51, RAD52, CTF4, HEX3, RTT109, and THP1, the histone 
HTZ1, and the telomere maintenance protein EST1.  Thus, while deletions of these genes 
may possibly increase phenotypic variation, the most plausible biological explanation for 
the increased cell-to-cell variation between these strains is that they are no longer clonal 





FIGURE 3.12  GENES KNOCKOUTS THAT INCREASE VARIANCE ACROSS MANY 
MORPHOLOGICAL TRAITS TYPICALLY AFFECT GENOMIC STABILITY.  A 
histogram comparison of the median phenotypic CVs observed for deletion strains 
versus replicate analyses of wild-type cells shows that deletion strains with the 
most reduced CVs are essentially wild-type-like in character, while those with the 
most increased CVs show significantly more cell-to-cell variability than wild-type 
cells.  These latter knockout strains carry deletions for genes predominantly 
involved in maintaining genomic integrity.  This trend is therefore likely to have 
arisen from non-clonal genetic variation in these strains, recapitulating the classic 
mutator phenotype.  Data from [16].  Figure used by permission [1]. 
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The functional network predicts yeast orthologs of human disease genes 
The network’s effectiveness at predicting both qualitative and quantitative yeast 
phenotypes suggests the possibility of application to other organisms, such as for 
predicting human disease genes.  I evaluated the applicability of the functional network 
GBA approach to predicting human disease by performing a similar AUC analysis on 
yeast orthologs of human diseases. I used human diseases from OMIM [68], while 
treating disease variants of a single disease as one category.  I mapped human disease 
genes and yeast genes in the functional network to their human-yeast ortholog group 
using InParanoid.  Using the method described above, I then calculated the AUC (as a 
measure of predictability) of the yeast orthologs of human genes for diseases that 
involved at least 4 human-yeast ortholog groups of which at least 4 yeast orthologs 
existed in YeastNet.  Perhaps surprisingly, phenotype predictions from the functional 
network are robust across species boundaries.  Yeast orthologs of human disease genes 
can be predicted by the functional network as demonstrated in Figure 3.13 for 28 OMIM 
diseases involving four or more yeast orthologs.  Not only are many of the yeast 
orthologs of these disease genes predictable, the median predictive accuracy of these 
phenotypes is even slightly higher than the genome-wide yeast phenotypes (Figure 3.3), 
a probable reflection of the fact that genes conserved between yeast and humans 
generally compose core cellular machinery, well-captured by the gene network.  As an 
illustration of this, the highest scoring human disease (AUC = 0.998), leukoencephaly 
with vanishing white matter, results from mutations in any of the subunits of the 
translation initiation factor EIF2B [69].  Likewise, I observed strong predictability for 
hemolytic anemia (AUC = 0.89), which involves 11 ortholog groups, involved in 
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glycolysis and glutathione metabolism, which are linked primarily by co-expression and 
co-citation, with only a few physical interaction-based linkages.  
Although this test was limited to diseases involving biological processes shared 
between human and yeast, these results support the notion that an integrated human 
functional network would guide the discovery of new disease genes.  As I observe strong 
disease predictions both from protein complexes (as in leukoencephalopathy) and 
pathways (as in hemolytic anemia), it appears likely that a functional human gene 
network might offer strong predictions for genes associated with diverse human diseases, 






































FIGURE 3.13  YEAST GENES WHOSE HUMAN ORTHOLOGS ARE LINKED TO THE SAME 
DISEASES ARE PREDICTED SIGNIFICANTLY BETTER THAN RANDOM 
EXPECTATION. Predictability is measured as the area under a ROC curve (AUC) 
as in Figure 3, measuring the AUC for each of 28 human diseases reported in the 
OMIM disease database [23] that have four or more yeast orthologs annotated in 
the yeast function network and plotting the resulting AUC distributions.  Real 
disease gene sets are significantly more predictable than size-matched random 
gene sets drawn from the set of yeast-human orthologs.  Box plots are drawn as in 




Extending a genetic screen by network-guided reverse genetics 
To this point, my analysis of the predictive power of the network had used a 
computational approach to demonstrate its power to retrieve known results.  However, for 
organisms in which reverse genetics is feasible, the observation that phenotypes can be 
predicted from network connectivity opens the possibility of extending genetic screens in 
a directed fashion.  That is, when in possession of a set of genes known to give rise to a 
phenotype of interest, rather than randomly screening to identify additional genes, one 
could instead exploit the predictability of phenotypes by directly screening genes that are 
most strongly connected to the known set in the network.  In this manner, experiments 
could be focused on the genes most likely to give rise to the phenotype.  So, I sought to 
experimentally demonstrate the predictive power of the network using a seed set of 
genes, while simultaneously extending a high-throughput screen, in a fashion similar to 
the extension of the screen for novel shmoo localized proteins as discussed in the 
previous chapter.  However, in this case, rather than re-testing to reduce false negatives, I 
wanted to screen additional genes that had not been previously tested in an initial screen.  
I decided to extend a previously published screen [4] of non-essential genes that result in 
a simple morphological defect, cell elongation, by testing essential genes.  Among 
nonessential genes, 145 genes (3.3%) have been identified that give rise to elongated 
morphologies in homozygous diploid deletion strains, of which 77 genes (1.7%) show a 
strong phenotype [4].  I selected these 77 genes as a seed set and found the phenotype to 
be reasonably predictable from the network using ROC analysis (AUC = 0.74).  Using 
the GBA method, I predicted the top 35 essential genes, which were not tested in the 
screen [4, 66], and were able to assay 33 of these strains for the elongate phenotype using 
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a tetracycline-downregulatable library.  For a negative control, 17 strains from the same 
library not linked to known elongate genes were also assayed.  I examined conditional 
loss-of-function strains for elongated cell morphologies, performing light microscopy of 
yeast strains carrying tetracycline-downregulatable alleles of each candidate gene [13].  
Sixteen (~48%) of the 33 tested were elongated, as shown for several examples in Figure 
3.13.  Only one negative control was elongated, which had been previously identified by 
Mnaimneh et al. [13].  The results represent an 8-fold improvement over the negative 
control set and a >15-fold improvement over genome-wide screening, confirming a set of 
predictions experimentally while also validating the general strategy of network-guided 
genetic screening. 
 
My rate of elongation identification is 8-fold higher than the negative control set 
and greater than 15-fold higher than the genome-wide screen, which demonstrates the 
utility of network-informed genetic screens and confirms that GBA phenotypic 





FIGURE 3.13  NETWORK-GUIDED EXTENSION OF A GENETIC SCREEN.  GBA was 
applied to predict essential yeast genes whose disruption resulted in elongated 
yeast cells, based on the genes’ network connectivity to a seed set of 77 
nonessential genes already known to cause cell elongation when deleted [4]. Five 
examples of successful predictions, observed in yeast strains carrying 
tetracycline-downregulatable conditional alleles [13] of the essential genes TAF9, 
MED6, MED7, SWI1, and RPO21. By contrast, conditional down-regulation of 
an unrelated essential gene, SCM3, caused no such cell elongation.  See Figure 
3.14 for additional details.  Figure used by permission [1]. 
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To gain further insight into the genes identified, I examined the network 
connections among the seed genes and newly identified genes giving rise to the elongated 
phenotype (Figure 3.14).  Strikingly, functional analysis of the elongate genes recovered 
indicates that the elongate phenotype is linked to the disruption of core transcriptional 
machinery, with the genes associated with elongated yeast cell morphology strongly 
enriched for core transcriptional functions (for example, they are significantly enriched 
for the MIPS [70] annotation “mRNA synthesis”, P < 10
-12
 [67]).  The set of newly 
identified genes predominantly belong to the RNA polymerase II mediator complex and 
associated transcriptional machinery.  Specifically, the genes recovered in the targeted 
screen are subunits of the RNA polymerase II mediator complex (MED6, MED7, both 
previously identified by [23], and MED8), and the transcription initiation complexes 
TFIID and SAGA (TAF1, TAF5, TAF9, and TAF12), complexes required for RNA 
polymerase II transcriptional initiation.  This illustrates another advantage of network-
guided genetic screening: because candidate genes are selected directly from the gene 
network, functional connections are often already known among the genes, helping to 
guide later interpretation of the hits.  The relationship between an observed phenotype 
and the corresponding molecular defect is often mysterious: the mechanism is unknown 
by which defects in transcription initiation lead to elongated cells. Nevertheless, it 
demonstrates that the phenotypic predictions of the functional networks are accurate even 





FIGURE 3.14  NETWORK CONNECTIVITY PREDICTS GENES INVOLVED IN CELL 
ELONGATION.  16 of 33 tested essential genes (yellow circles) showed elongated 
cell phenotypes (see Figure 3.13) on the basis of their connections to the seed set 
genes (green circles), with particular enrichment for genes associated with RNA 
polymerase II transcriptional initiation and the mediator complex.  The color of 
the edge between two genes indicates the source of evidence supporting the 
functional link: thick black, multiple types of evidence; blue, affinity 
purification/mass spectrometry; green, literature mining by co-citation; cyan, gene 
neighbors or tertiary structure; pink, literature curated physical interaction; red, 






Just as functional networks propagate known functional annotations to un-
annotated genes, phenotype prediction via GBA is limited to propagating known 
phenotypes.  Therefore, an initial seed set of genes is required, such as might result from 
a genetic screen for the phenotype of interest, before being able to apply the network in 
order to identify more such genes.  I might also expect genes in the same pathway to 
often exert inverse effects on a phenotype, acting either as activators or repressors.  I will 
discuss this further in the next chapter, because my next area of research suggests that 
there may be ways to find “inverse” phenotypes when a number of activators and 
repressors are involved in a given pathway.  Despite possible complicating factors, I 
demonstrate that GBA can be successfully applied to identify genes giving rise to similar 
loss-of-function phenotypes.  Furthermore, network-guided phenotype prediction can be 
used to extend a genetic screen in a targeted fashion by providing a ranked list of 
potential candidates for evaluation.  In principle, the screen might be expanded by adding 
the newly identified genes to the seed set and iterating the prediction and testing.   
 
In particular, large-scale reverse genetic screens using yeast mutant strain 
collections have become increasingly common [71].  However, as seen in my chapter on 
shmoo localization, large-scale assays often suffer from high false negative rates.  In 
many cases, the primary source of false negatives may be the limited scope of libraries 
used in screening (e.g., screening only the nonessential or essential genes).  Such partially 
genome-wide screens can benefit by following up the initial screen with focused 
screening (or re-screening) of prioritized candidate genes.  In order to facilitate such 
efforts, I have created a web server [69] which allows interactive analysis of a seed gene 
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set, performing ROC analysis to assess the predictability of the phenotype, then returning 
a ranked list of candidate genes most likely to share the same loss-of-function phenotype. 
 
Note that I have focused on predicting loss-of-function phenotypes because of the 
large number of genome-wide screens available; it is not clear that gain-of-function 
phenotypes will be similarly predictable.  However, the recent construction of yeast over-
expression libraries [72-74] should soon allow testing of network-based prediction of 
such phenotypes. 
 
Why are loss-of-function phenotypes predictable? 
The results indicate that typical phenotypes represent specific enough defects that 
they are predictable based upon the genes’ functional associations. I observe multiple 
mechanisms for how loss of different genes leads to disruption of the same 
phenotypically relevant process, primarily participation in the same protein complex or 
membership in the same biological pathway.  These results are consistent with the partial 
predictability of human disease from protein complex membership [62, 63] and of the 
prediction of knockout phenotypes of annotated yeast genes on the basis of pathway 
annotation [64], which I illustrate with the following contrasting examples from among 
my predictions.  In Figure 3.6A, the proteins ANP1, MNN9, MNN10, MNN11, VAN1 
are members of the same alpha-1,6-mannosyltransferase protein complex.  Chitin 
accumulates when the function of the complex is disrupted by the loss of any one of the 
five members [32].  In contrast, in Figure 3.6B, the three genes THR1, THR4, and HOM6 
are involved in the biochemical pathway that converts homoserine to threonine; these 
genes are linked in the functional network [11] by virtue of the coordinate expression of 
their bacterial homologs in operons (e.g., as for the Bacillus subtilis homologs ThrB, 
 78 
ThrC, and ThrA ), even though there is as yet little evidence that they belong to the same 
physical complex.  The loss of any of the three genes disrupts the threonine synthesis 
pathway and leads to reduced growth after 5 generations in threonine-depleted media [4].  
The functional gene network, which combines both physical and functional interactions, 
predicts both classes of phenotypes effectively, whether resulting from disruption of 
physical complexes or pathways. 
 
Nevertheless, some phenotypes are not significantly predictable.  Three likely 
causes exist:  First, poor predictability may result from using genome-wide screens with 
high false positive rates, which would base predictions on incorrectly identified seed sets.  
I sought to minimize this type of error by adopting stringent thresholds for each 
phenotype.  Second, incomplete screens (e.g., such as by not testing the essential genes), 
high false negative rates, and the stringent phenotype thresholds that I selected could lead 
to a large number of positive examples being excluded from the seed sets.  Such omitted 
positive examples scoring higher than seed genes would artificially depress prediction 
accuracies.  Third, unpredictable phenotypes could in principle arise from the disruption 
of functionally unrelated genes.  In order to test this, I compared the GO enrichment for 
the 25 most predictable phenotypes with the 25 least predictable phenotypes.  For each 
phenotype, I identified the GO term with the most significant enrichment of genes 
annotated with the term, measured using the hypergeometric distribution.  Using a 
significance threshold of p < 10
-7
, I find that 18 of the 25 highly predictable phenotypes 
are significantly enriched for at least one GO annotation, versus only 2 of the 25 poorly 
predictable phenotypes.  This suggests that poorly predictable phenotypes largely result 
from sets of genes with little functional coherence. 
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AUC is a useful measure of gene functional coherence 
By definition, the GBA approach predicts phenotypes associated with functionally 
coherent sets of genes, presumably reflecting the clustering of the genes in the functional 
network.  Such predictability, which I specifically measure as the AUC, can therefore be 
regarded as a direct estimate of the functional coherence of the seed gene set.  Thus, 
beyond simply evaluating phenotype prediction, the AUC offers an additional measure of 
functional coherence that complements other existing measures, such as the enrichment 
of GO annotations or other biologically meaningful sets of genes (e.g., as calculated by 
FunSpec [67] or DAVID [75]). For example, the five genes giving rise to the branched 
cell phenotype are connected by six linkages in the network (AUC = 0.87), but only a 
single pair shares any GO annotation (p < 0.001, for the GO term “transcription from 
RNA polymerase II promoter”).  The network-based AUC measure for functional 
coherence leverages the massive unbiased data integration of functional networks, 
extending well beyond known annotations, and allows estimates of functional coherence 
even among unannotated genes or those spanning multiple systems. 
 
In principle, the AUC approach can therefore measure the functional coherence of 
genes that annotation-based methods will miss.  Beyond unannotated genes, the AUC-
based estimate of functional coherence might also work effectively when the genes under 
study span multiple functional categories—each category may only be partially enriched 
and therefore otherwise be missed for lack of signal.  The functional network, however, 
considers pairwise linkages, not predetermined categories, so has the potential to identify 
linked genes across multiple annotation categories. 
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Recapitulation of the classic mutator phenotype in the yeast knockout collection  
I observed a strikingly higher predictability for mutations that increased cell-to-
cell phenotypic variation versus those that decreased it.  The deletion strains exhibiting 
higher CVs tended to be consistent across the complete set of CV phenotypes examined, 
with the deleted genes showing strong enrichment for functions related to DNA repair, 
recombination, and genomic stability. Note that strains with the lowest CV phenotypes 
showed neither predictability nor functional enrichment—in fact, the CVs exhibited by 
these strains were similar to those observed for replicate analyses of wild-type cells 
(Figure 3.12), suggesting that the strains that most decreased cell-to-cell variation were 
essentially wild-type-like in this regard.   
 
This outcome is consistent with a recapitulation in the yeast deletion strain 
collection of the classic mutator phenotype.  The mutator phenotype was originally 
observed in DNA repair mutants—such mutants accumulated mutations so rapidly that 
they showed high variability in colony sizes when grown on Petri dishes, high variability 
in cell morphologies, high rates of plasmid loss, and increased spontaneous mutagenesis 
(e.g., as previously observed for RAD27 and RAD52 deletion mutants [76, 77]).  The 
most likely explanation is therefore that strains in the deletion collection harboring 
deletions in genes related to genomic stability have simply accumulated mutations at a 
higher rate.  A mixed population, no longer clonal, would be expected to exhibit more 
cell-to-cell variation than other deletion strains, which would accumulate mutations at a 
lower rate.  Thus, I suspect that the phenotypic analysis is correctly revealing the 
functional signature of a legitimate phenotype inadvertently captured in the process of 
distributing and passaging the yeast deletion strain collection. 
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Applying network-based phenotype prediction to humans and other organisms 
In principal, the approach I describe could be applied for any organism, using 
functional network data, if available, or in the absence of such data, using physical 
interaction data, such as available protein interaction networks for fly [78], worm [58], or 
human [25, 79-83].  In the absence of an integrated functional gene network or protein 
interaction network, I expect that networks of mRNA co-expression associations, such as 
can be derived from DNA microarray data, would provide some utility for phenotype 
prediction.  Such data are a major contributor to functional gene networks (e.g., [9, 84, 
85]) and are relatively easily generated from available data for most model organisms.   
 
In particular, application of this approach in humans may allow directed 
identification of disease genes.  Indeed, functional linkages derived largely from known 
Gene Ontology annotation [86] or protein interactions [62] have shown some utility for 
prioritizing positional candidate genes from genome-wide linkage screens.  However, the 
results show that across a wide range of yeast phenotypes and human diseases the 
associated genes (or their yeast orthologs) can be directly identified even in the absence 
of supporting genetic loci data.  In order to apply my approach to human diseases, genes 
known to be associated with a particular disease, such as found from twin or genome-
wide association studies, would form the seed set.  Additional candidate genes likely to 
be associated with that disease could then potentially be identified or prioritized based 
upon their network connections to the seed set, using the guilt-by-association principle.  
Potential disease genes could then be tested in disease model systems or screened 
genetically in a focused manner.  Such a directed approach would leverage the 




In summary, I have demonstrated that yeast gene loss-of-function phenotypes are 
broadly predictable from connectivity in a functional gene network, with examples 
presented spanning a wide range of cell growth, cell morphology, metabolite transport, 
chemical sensitivity, and molecular phenotypes.  I demonstrate that this predictability can 
be used to extend genetic screens in a directed fashion, and that this approach might 
therefore be important in organisms for which genetics is difficult.  Furthermore, based 
on a computational analysis of gene linkage among yeast-human orthologs involved in 
disease, I suggest that a similar approach in humans might enable the directed discovery 
of disease genes.  In the following chapter, I will discuss another strategy for predicting 
phenotype across species that was inspired by this observation and others. 
 
This work is published in Genome Biology [1] from which this chapter is 
reworked and expanded upon. 
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Chapter 4: Predicting and testing human disease genes in model 
organisms by finding equivalent phenotypes between species. 
 
INTRODUCTION 
Identifying genes responsible for human disease is often challenging, at least in 
part because phenotypic assays are frequently not possible.  In addition, genome-wide, 
blind genetic studies for mutation/disease correlation often require much more data than 
can be easily collected and often run the risk of not passing a significance threshold due 
to corrections for multiple testing.  Therefore, it is desirable to find high confidence 
candidate genes that are strongly evidenced to play a causative role in the disease of 
interest, prior to screening. 
 
My previous two projects demonstrated that the yeast functional network 
effectively predicts genes for targeted screens of both intracellular protein localization 
and organismal phenotype.  Furthermore, I found that the network could predict yeast 
orthologs of human diseases.  The logical extension of this research program is to show 
that the functional network can provide a rational, quantitative approach for prioritizing 
candidate disease genes across species and to evaluate which organisms are appropriate 
models for a given disease.  As illustrated in the previous chapter by the yeast cell 
elongation phenotype and the human disease leukoencephaly, once a phenotype or 
disease is traced to the disruption of a gene, the phenotypic outcome of the disruption of 
related genes can be predicted even without understanding the exact mechanism that 
gives rise to the phenotype. 
 
 92 
However, it is not always possible to predict the exact phenotypic outcome of 
disrupting an ortholog present in one species from the gene disruption phenotype of 
another species.  For example, 3 of 4 genes that are implicated in leukoencephaly in 
humans have yeast orthologs that are essential and the other is sensitive to growth in 
synthetic complete minus tryptophan media.  Even more starkly, mutating the RB1 gene 
in humans gives rise to retinoblastoma [1], a cancer of the retina, yet disrupting the RB1 
ortholog (and a second redundant gene) in the nematode C. elegans gives rise to ectopic 
vulvae [2]. Mutant phenotypes are thus an emergent property of the system; disruptions 
of equivalent genes with conserved molecular functions, but in different systems 
contexts, can lead to different outcomes. It becomes clear that to test the prediction of 
human disease genes in model organisms it is necessary to start by finding phenotypes 
that are in some way equivalent across species.  However, diverse genetic perturbations 
can give rise to the same phenotypic outcome (degeneracy), while mutation of a single 
gene can lead to multiple phenotypic outcomes (pleiotropy). Genes and phenotypes thus 
have a many-to-many relationship, and mapping equivalent phenotypes between 
organisms is non-obvious.  Nonetheless, once equivalent phenotypes are identified, 
screens for additional mutations that lead to a phenotype in the model organism may 
provide high confidence candidate genes for a phenotype/disease in the reference 
organism. 
 
But, can we tell if a particular disease model is equivalent enough to the human 
case to be useful? Can this property be quantified, allowing ranking of models according 
to utility? Are there non-obvious models for human disease, perhaps hidden by 
differences in emergent appearance? Importantly, a model does not have to exactly 
reproduce symptoms of a disease to be useful. Thousands of genome-wide mutational 
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analyses have now been performed, associating genes to phenotypes in model organisms, 
e.g., yeast, worms, and mice, at a far higher rate than for humans (Figure 4.1). 
 
Identifying and expanding models of human disease 
I demonstrate a three step process for identifying cross-species models of human 
diseases.  First, I identify equivalent phenotypes based on the shared involvement of 
orthologous genes involved in phenotypes from two species.  Second, I test genes in the 
model organism for the disease equivalent phenotype and choose genes that are naturally 
predicted by the overlapping phenotypes or by being closely linked network neighbors as 
suggested in my previous chapter.  Third, I test the candidate genes for their phenotypic 
outcome in the original organism, or appropriate surrogate. 
  
Identifying equivalent phenotypes (phenologs) 
As a framework for considering equivalent phenotypes, my research introduces 
the notion of orthologous phenotypes, defined as phenotypes related by the orthology of 
the associated genes in two organisms, and corresponding to the phenotype-level 
equivalent to gene orthologs. Orthologous phenotypes derive from sets of genes in two 
organisms such that the genes in each organism are associated with the same phenotype 
(phenotypes can differ between the organisms), and the associated gene sets overlap 
significantly (i.e., are enriched for the same orthologous genes) (Figure 4.2). 
Orthologous phenotypes are evolutionarily conserved outputs of conserved systems of 
genes, which can manifest as different traits or structures in different organisms due to 
organism-specific context effects. The human retinoblastoma eye cancer and the C. 
elegans synthetic multivulval phenotype are orthologous, with failures of orthologous 
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genes performing equal molecular functions in different contexts causing different 
phenotypic outcomes. Orthologous phenotypes thus bridge the molecular definitions of 
homologous and orthologous genes [3] with classic definitions of homologous structures 
from Owen [4] and Darwin [5], deriving from considerations both of gene heredity and of 
the traits/structures affected by perturbing the genes.  I will refer to orthologous 




FIGURE 4.1  THE RATE OF ASSOCIATING GENES TO ORGANISM-LEVEL PHENOTYPES 
IN MODEL ORGANISMS GREATLY EXCEEDS THAT IN HUMANS (data from [6-
10]). Thus, appropriate mapping of model organism phenotypes to human 
diseases could significantly accelerate discovery of human disease gene 
associations. Orthologous phenotypes (phenologs) offer one such approach.  






FIGURE 4.2  PHENOLOGS CAN BE IDENTIFIED BASED ON SIGNIFICANTLY 
OVERLAPPING SETS OF ORTHOLOGOUS GENES (A is orthologous to A’, B to B’, 
etc), such that each gene in a given set (green box or cyan box) gives rise to the 
same phenotype in that organism. The phenotypes may differ in appearance 
between organisms due to differing organismal contexts. As gene-phenotype 
associations are often incompletely mapped, genes currently linked to only one of 
the orthologous phenotypes become candidate genes for the other phenotype (e.g., 
the ortholog of gene D in organism 2 is a new candidate for phenotype 2).  Figure 
adapted from work in review [42]. 
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Phenologs can be identified by assembling known gene-phenotype associations 
for two organisms, considering only genes that are orthologous between the two 
organisms, then testing each inter-organism phenotype pair for significant gene overlap 
based upon three observations: (1) the total number of orthologs in organism 1 that give 
rise to phenotype 1; (2) the total number of orthologs in organism 2 that give rise to 
phenotype 2; and (3) the number of orthologs shared between these two sets. The 
significance of a phenolog can be calculated from the hypergeometric probability of 
observing at least that many shared orthologs by chance. Figure 4.3 shows an example: 
the set of human genes (with worm orthologs) associated with X-linked breast/ovarian 
cancer significantly overlaps genes whose mutations lead to a high frequency of male 
progeny in C. elegans. Male C. elegans are determined by a single X chromosome, 
hermaphrodites by 2 copies; thus, X chromosome non-disjunction leads to higher 
frequencies of males [11]. Human breast/ovarian cancers can derive from a similar 
mechanism, e.g. as for sporadic basal-like breast cancers [12], supporting the notion that 
this phenolog is identifying a useful disease model. 
 
Finding genes in model organism for orthologous phenotype 
The breast cancer/male progeny example above demonstrates that candidate 
disease genes in the reference organism can be identified immediately if they are already 
known to result in the orthologous phenotype upon disruption.  Human orthologs of the 
13 additional genes associated with the worm trait are reasonable candidate genes for 
involvement in breast/ovarian cancers. Nine of these genes were not yet included in the 
databases I employed, but could be confirmed in the primary literature to be linked to 
breast cancer (e.g., as for the breast cancer biomarker KIF15 [13]); 4 genes (GCC2, 
PIGA, WDHD1, SEH1L) remain as breast cancer candidate genes (Figure 4.3). The 
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worm phenotype thus predicts and suggests additional genes relevant to human breast 
cancer.  Furthermore, additional candidates can be identified by targeted screening using 
guilt by association in the functional network of the target organism, using currently 
known genes as the seed set, where known genes can either those involved in the overlap 
(identified by k in Figure 4.2), or the entire set of genes involved in the model organism 
phenotype (k and n2 in Figure 4.2).  Later in this chapter, I will discuss the positive 
results of the attempt to experimentally validate this approach. 
 
Testing candidate genes 
Once candidate genes are identified they can be evaluated for their involvement in 
the disease phenotype in a number of ways depending on the specific phenotype.  For 
some phenotypes, candidate genes can be adequately tested by knockout or knockdown 
in cell or tissue culture.  In other cases, the genomic region surrounding candidate genes 
can be targeted for sequencing to identify mutations in affected individuals.  In this work, 
we utilize a third approach, where candidate genes from simple organisms are tested in a 




FIGURE 4.3  AN EXAMPLE OF A PHENOLOG MAPPING HIGH INCIDENCE OF MALE C. 
ELEGANS PROGENY TO HUMAN BREAST/OVARIAN CANCERS (details in text).  




Collection of phenotypes 
I collected gene-phenotype associations from the literature for four species 
(worm, yeast, mouse, and human). For human phenotypes, I used employed human 
diseases from the OMIM database [14], using the compressed OMIM disease categories 
previously described in McGary et al. [15], such that multiple variants of a disease were 
grouped together. (For example “Corneal dystrophy, hereditary polymorphous posterior” 
and “Corneal dystrophy, lattice type I,” reduce to a single category of corneal 
dystrophies). Mouse gene-phenotype associations were downloaded from MGI [16] 
(MGI_PhenoGenoMP.rpt; downloaded on April 21, 2008). Gene-phenotype associations 
involving more than one locus or that could not be linked to an Entrez Gene were 
removed. MGI identifiers were converted to Entrez GeneIDs using MGI_Coordinate.rpt 
(downloaded April 25, 2008).  MGI mouse phenotype descriptions were from 
VOC_MammalianPhenotype.rpt, downloaded May 7, 2008. All MGI data were 
downloaded from ftp://ftp.informatics.jax.org/pub/reports/index.html. The MGI 
associations were supplemented with a small number of broadly defined mouse 
phenotypes obtained from http://hugheslab.med.utoronto.ca/supplementary-data/
mouseFunc_I/MGI_phenotype.txt, but which are ultimately derived from MGI data.  
Worm gene-phenotype associations were assembled from the literature-reported RNAi 
studies assembled in Lee et al. [17] supplemented by the addition of phenotype data 
downloaded from WormBase 188 [7] (ftp://ftp.wormbase.org/pub/wormbase/acedb/
WS188/). Worm gene-phenotype association data come from 
phenotype_association.WS188.wb, phenotype descriptions from 
phenotype_ontology.WS188.obo, and gene information from geneIDs.WS188.gz.  Files 
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were downloaded on March 26, 2008.  WormBase phenotypes were filtered for positive 
associations only. All allelic variants and RNAi data were reduced to gene-phenotype 
pairs. Gene IDs (e.g. WBGene00044645) were translated to sequence names (e.g. 
Y51H7BR.8) using geneIDs.WS188.gz. Of approximately 22K gene-phenotype pairs, 
384 could not be linked to a sequence name. These derived primarily from uncloned 
genes and were thus omitted from further analysis. Yeast gene-phenotype associations 
were obtained from McGary et al. [15] (a literature compilation plus SGD [8]), 
supplemented with associations from a recent set of genome-wide screens of drug 
sensitivity [18] (homozygous and heterozygous screens, 
het.z_tdist_pval_nm.goodbatch.pub  hom.z_tdist_pval_nm.pub downloaded from 
http://chemogenomics.stanford.edu/supplements/global/download/data/). All gene-
phenotype associations from the drug screens were filtered using the authors’ 
recommended cutoff of p<1x10
-5
. For the purposes of calculating phenologs, I considered 
only a subset of the gene-phenotype associations plotted in Figure 1A, analyzing only 
those implicating single genes (i.e., not genetic interactions or traits requiring 
simultaneous mutation of multiple loci), and only those phenotypes in which a defect was 
observed (i.e., omitting genes associated with the phenotype “normal”, “wild-type”, “no 
effect”, or other such cases.) 
 
Identification of non-redundant phenotype sets 
In order to minimize the number of redundant comparisons performed, all 
phenotype-associated gene sets within a single organism were tested for significant 
overlap and non-redundant sets were selected for subsequent analyses. Within each 
organism, phenotypes were identified that reciprocally covered ≥80% of each other’s 
genes; for each such pair of phenotypes, only the phenotype with the greater number of 
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genes was retained. (For example, in mouse, genes associated with defects in the small 
petrosal ganglion and small nodose ganglion overlap considerably. The former has 9 
associated genes, of which a subset of 8 is also associated with the latter phenotype; only 
the former was retained.) 
 
Calculating Orthologs 
Orthologs between species were calculated using the following translated 
genomes: Human, ftp://ftp.ncbi.nih.gov/genomes/H_sapiens/protein/protein.fa.gz, 
downloaded on Feb. 7, 2008; Mouse, ftp://ftp.ncbi.nih.gov/genomes/M_musculus/
protein/protein.fa.gz, downloaded Oct. 13, 2007; Worm, ftp://ftp.wormbase.org/pub/
wormbase/data_freezes/WS170/sequences/wormpep170.tar.gz, downloaded on Feb. 19, 
2007; Yeast, ftp://genome-ftp.stanford.edu/pub/yeast/sequence/genomic_sequence/
orf_protein/ orf_trans.fasta.gz, downloaded Feb. 19, 2007. 
 
For human and mouse proteomes, I analyzed only sequences with protein refseq 
identifiers (NP_ only). For humans, 43 genes without Gene IDs were removed (mostly 
hypothetical proteins).  For mouse, three proteins without current records were removed. 
 
In order to identify orthologous genes in different species, orthologs were 
calculated using INPARANOID v. 1.35 [19] with default parameters, using blastall 
2.2.15 also with default parameters. All genes assigned as orthologs (strictly speaking, 
ortholog groups or orthogroups, due to inclusion of in-paralogs) by INPARANOID were 
kept, regardless of their INPARANOID score. Using orthogroups, rather than 
bidirectional best hits, captures the many-to-many relationships that exist for gene 
duplicates that exist in more than one copy in one or both species. In order to prevent 
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isoform variations from resulting in skewed blast results, mouse and human sequences 
with the same Entrez GeneID but separate RefSeqIDs were treated separately in 
INPARANOID. Following INPARANOID analysis, orthologs sharing GeneIDs were 
combined so that gene variants would be considered together in subsequent analyses. 
 
Calculation of phenologs 
For each pair of species, I first converted gene-phenotype associations to 
ortholog-phenotype associations using the orthologs calculated by INPARANOID. In 
cases were paralogous genes within an organism result in the same phenotype, multiple 
gene-phenotype associations thus collapse to a single ortholog-phenotype association, 
which eliminates artificial inflation of the significance of ortholog overlap. Second, I 
compared the set of orthologs associated with a given phenotype within one species 
(species 1) to the set of orthologs associated with a given phenotype in the second species 
(species 2), repeating this analysis for all pairwise comparisons of phenotypes from 
species 1 and species 2. For each pair of phenotypes in which the ortholog sets 
overlapped (shared members), I calculated the probability of the overlap due to chance 
using the cumulative hypergeometric distribution, where N is the total number of 
orthologs shared between the two species; n and m are the number of orthologs linked to 
the species 1 and species 2 phenotypes, respectively; and k is the number of common 






The hypergeometric probability does not correct for multiple comparisons, so I 
estimated the false discovery rate with an empirical permutation test. I performed 1,000 
random permutations of the ortholog-phenotype associations, for each permutation 
repeating the all versus all phenotype comparison using ortholog set sizes identical to 
those associated with the actual phenotypes. Significant phenologs were identified at a 
false discovery rate of 0.05 by ranking real & permuted phenologs on the basis of the 
associated hypergeometric probabilities and selecting a threshold of probability where the 
proportion of permuted phenologs above the cutoff accounted for 5% of the phenologs. 
 
Tests of sub-network modularity 
I measured the degree of network interconnectivity among orthologs involved in 
overlapping phenotypes from yeast and worms using a modification to a recently 
developed measure of the network clustering of a set of genes [15, 17]. Given a query set 
of genes, their interconnectivity in a functional gene network (a gene network with edge 
weights corresponding to the log likelihood of the linked genes functioning in the same 
biological process [17, 20]) is calculated as the area under a receiver-operator 
characteristic curve (AUC) for predicting back members of the query gene set when rank-
ordering all genes in the network by each gene’s sum of edge weights to the query gene 
set (corresponding to the naïve Bayes probability of participating in the same process as 
genes in the query set), performing the test using cross-validation (each query gene is 
omitted in turn from the query set for purposes of its evaluation). AUC ranges from 0 to 
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1. A high AUC indicates that query genes are more tightly connected in the network to 
each other than to other genes, while an intermediate AUC (near 0.5) corresponds to no 
better than random recovery of query genes, indicating negligible interconnectivity of the 
query gene set in the network. (AUC values in the range of 0 to near 0.5 indicate worse 
than random expectation, e.g., systematically lower connectivity of the query set).  
 
To analyze phenolog gene sets, I modified the method by converting the gene-
centric functional networks [17, 20] into networks of orthologs based upon 
INPARANOID ortholog assignments. I retained only network edges connecting 
orthologs present in both yeast and worm. In the case that multiple genes are assigned to 
a single ortholog, multiple network edges could exist between a pair of orthologs; I 
retained only the edge with the greatest weight (confidence).  The resulting yeast and 
worm networks thus each contain ortholog-ortholog functional associations, rather than 
gene-gene associations. Using these two networks, I calculated AUC as in [15, 17]: for a 
given ortholog query set (e.g. the set of orthologs in the intersection of a phenolog), I 
rank ordered all orthologs shared between yeast and worm by the sum of the edges 
connecting them to the query set, then calculated AUC for recovery of the query ortholog 
set using cross-validation.  
 
I calculated network AUC for genes (orthologs) within and outside of phenolog 
intersections (Figure 4.7), considering all significant (5% FDR) yeast-worm phenologs 
with at least 4 genes in both the phenolog intersection ortholog set and the ortholog set 
outside the intersection. In order to correct for possible query gene size effects, I sub-
sampled the larger of the two sets. For example, if the intersection of a worm phenotype 
and a yeast phenotype has 30 orthologs and the yeast phenotype has 15 additional 
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orthologs, I calculated the AUC of the 15 additional orthologs, then randomly sampled 15 
genes at a time from the intersection set, calculating the AUC of each subset of 15 genes, 
taking the median value of 100 such samplings as the AUC for the intersection set. 
 
Treatment of animals 
Animal care met the principles and guidelines of the Institute for Laboratory 
Animal Research ‘‘Guide for Care and Use of Laboratory Animals’’ and the University 
of Texas at Austin Institutional Animal Care and Use Committee. 
 
Xenopus laevis embryo manipulations 
Female Xenopus laevis were ovulated overnight after injecting human chorionic 
gonadotropin, and eggs were squeezed out for fertilization in vitro. At the two cell stage, 
the jelly layer of embryos was removed by swirling in 3% cysteine (pH 7.9) in 1/3x 
MMR medium and washed in 1/3xMMR five times. For microinjections, embryos were 
placed in 2% Ficoll in 1/3xMMR, and injected using forceps and an Oxford universal 
micromanipulator, then reared in 2% Ficoll in 1/3xMMR to stage 9, then washed and 
reared in 1/3xMMR.  
 
Whole-mount in situ hybridization was performed using a modified method 
omitting acetylation steps from the standard method [21]. For all experiments, 
morpholino antisense oligonucleotides (MOs) were injected at 20-60ng/blastomere.  To 
target ciliated epidermis, injections were made into the two ventral cells at the 4 cell 
stage. Two dorsal cells were injected to analyze neural tube closure. The posterior 
cardinal vein and intersomitic veins were targeted by injecting into the two ventral cells 
equatorially at the 4 cell stage. For whole mount in situ hybridization for Erg and XMsr, 
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embryos were fixed in MEMFA medium at stage 34 to 36. The hemorrhage phenotype 
was photographed at stage 45 after anesthetizing with Benzocaine.  
 
Images of embryos were obtained with a Leica MZ16FA stereomicroscope using 
ImageProPlus software. 
 
All methods involving Xenopus were performed by Tae Joo Park.   
 
Confocal imaging 
For epidermal cilia staining, embryos were fixed in MEMFA at stage 25 to 27 and 
washed with Ptw solution (PBS+0.1% Tween-20). The embryos were incubated with 
mouse anti-α-tubulin IgG in Ptw for 30 min. After washing with Ptw, the embryos were 
incubated with Alexa Fluor 555 goat anti-mouse IgG in Ptw for 30 min followed by 
washing in Ptw. Actin filaments were co-stained using Alexa 488 conjugated Phalloidin. 
In all cases, embryos were mounted in Ptw and 3D projections of cilia were made by 
collecting overlapping sections with a Zeiss LSM5 PASCAL confocal microscope. 3D 
projections, image processing, and image analysis were performed with LSM5, Image 
ProPlus, and Adobe Photoshop software.  All confocal methods were performed by Tae 
Joo Park.   
 
Morpholino oligonucleotides and cDNA clones 
xSox12, Erg, and XMsr cDNAs were obtained from Open BioSystem (xSox12: 
IMAGE:6636177, Erg: IMAGE:5512670, XMsr: IMAGE:8321886). Centrin-GFP was 
obtained from Dr. Chris Kintner at the Salk institute. Translation blocking antisense 
morpholinos for IFT140, RFX2, and xSox12 were designed based on the sequences from 
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the NCBI database (IFT140: x17243.1, RFX2: BC108517.1, xSox12: BC068647.1). MOs 
were obtained from Gene Tools. All MO sequences are listed below: 
IFT140-MO:  5’-TTCCTAAGGCACTCCAGTCACCCAT-3’ 
RFX2-MO:  5’-AATTCTGCATACTGGTTTCTCCGTC-3’ 
xSox12-MO:  5’-TCACCCTGTATGGTATCCATTTAAG-3’ 
xSox12-MM:  5’-TCAGCCTCTATGCTATGCATTCAAG-3’ 
 




To systematically discover phenologs, I collected from the literature a set of 1,923 
human disease-gene associations [6], 74,250 transgenic mouse phenotype-gene 
associations [9], 27,065 C. elegans gene-phenotype associations [7], and 86,383 yeast 
gene-phenotype associations [8, 10, 15, 18], spanning ~300 human diseases and >6,000 
model organism phenotypes. With these data and the sets of orthologous gene 
relationships between each pair of organisms [19], I quantitatively examined each inter-
organism phenotype pair, measuring the significance of each (Figure 4.4).  I corrected 
for testing multiple hypotheses by repeating all analyses 1,000 times with randomly 
permuted gene-phenotype associations to calculate a false discovery rate (FDR) based 
upon the observed null distribution of scores (Figures 4.5).  With this correction, I 
observe of 154 significant phenologs (5% FDR) between human diseases and yeast 
mutational phenotypes, 3,755 between human and mouse, 147 between mouse and worm, 
105 between mouse and yeast, and 206 between yeast and worm, and 9 between human 





FIGURE 4.4  SYSTEMATIC IDENTIFICATION OF PHENOLOGS. For a pair of organisms, 
sets of genes known to be associated with mutational phenotypes are assembled, 
considering only orthologous genes between the two organisms. Pairs of 
mutational phenotypes—one phenotype from each organism, each associated with 
a set of genes—are then compared to determine the extent of overlap of the 
associated gene sets, calculating the significance of overlap by the 




FIGURE 4.5  MANY MORE ORTHOLOGOUS PHENOTYPES ARE OBSERVED THAN 
EXPECTED BY RANDOM CHANCE as revealed by comparison of the distribution 
of observed probabilities with those derived from the same analysis following 
permutation of gene-phenotype associations, as shown in all pairwise 
comparisons of the mutational phenotypes from mouse, human, yeast, or worm.  





FIGURE 4.6  COUNT OF PHENOLOGS ABOVE A FALSE DISCOVERY RATE THRESHOLD 
for all pairwise comparisons of the mutational phenotypes from mouse, human, 
yeast, or worm.  Figure adapted from work in review [42]. 
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Phenologs identifies obviously equivalent phenotypes 
Many intuitively obvious phenologs are identified in this manner, which serve as 
positive controls: nonviable C. elegans (RNAi) are found to be phenologous to inviable 
yeast (gene deletion), given that of 705 worm genes (with yeast orthologs) associated 
with nonviability, and 653 yeast genes (with worm orthologs) associated with 
nonviability, 369 orthologs are shared between these sets (p ≤ 10
-33
). Embryonic lethality 
before somite formation in mice is found to be phenologous to nonviable C. elegans 
following RNAi (p ≤ 10
-5
). Mouse pre-/peri-natal lethality or embryogenesis defects are 
phenologous with sterility in C. elegans following RNAi (p ≤ 10
-6
). Many lethality, 
sterility, and embryonic developmental phenotypes are related across organisms. 
Importantly, many more specific phenologs are revealed, especially for the 
comparison of mouse and human phenotypes; these recapitulate many known mouse 
models of disease, serving as additional positive controls. Table 4.1 lists specific 
examples. For example, one of the most significant phenologs identified between human 
disease and mouse mutational phenotypes is that linking Bardet-Biedl syndrome with 
four mouse traits, each of which relates to the disruption of ciliary function (abnormal 
brain ventricle/choroid plexus morphology, small hippocampus, enlarged third ventricle, 
absent sperm flagella; all p ≤ 10
-11
), consistent with the apparent molecular defects in 
Bardet-Biedl syndrome [22]. The argument is thus that mouse ciliary defects provide a 
powerful model for studying human Bardet-Biedl syndrome, consistent with its recently 
recognized utility in this regard. Similarly, human cataracts are observed to be 
phenologous to mouse cataracts (p ≤ 10
-24
), human obesity is phenologous to mouse 
obesity (p ≤ 10
-14
), human deafness to mouse deafness (p ≤ 10
-29
), human retinitis to 
mouse retinal degeneration (p ≤ 10
-26
), and human goiter to mouse enlarged thyroid 
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glands (p ≤ 10
-8
). Thus, the calculation of phenologs correctly identifies many known 
mouse models of human diseases and therefore has the potential to identify new models. 
 
Techniques developed for identifying homologous genes can be applied to phenologs 
Much of the powerful conceptual framework established for gene sequence 
homology and orthology may be applicable to phenologs. For example, equivalent 
phenotypes might be defined on the basis of homologous, rather than orthologous, gene 
sequences, in this manner examining the divergence of phenotypic outcome of 
homologous systems. Similarly, many of the algorithmic approaches used to identify 
orthologous genes might also be applied to the identification of phenologs. I explored this 
notion for one effective and easily automated approach to identify orthologous sequences, 
the reciprocal best hit (RBH) strategy. The RBH criterion holds that genes X and Y are 
orthologs if gene X is the most similar sequence to gene Y when searched genome-wide, 
provided the reciprocal search is also true.  I adapted the RBH criterion to the 
identification of phenologs in order to identify the most equivalent phenotypes between 
two organisms from among those assayed, by asking if the phenotypes have the most 
significant (lowest p-value) gene overlaps with each other when searched against all 
phenotypes in their respective organisms. Such analysis gives a second criterion for 
identifying phenologs, useful for legitimate phenologs with poor p-values due to limited 
phenotypic data sets. Examples of such RBH phenologs are indicated in Table 4.1. 
 
Phenologs identify dense subnetworks in functional network 
Phenologs imply that although phenotypes diverge, the orthology of the 
underlying gene networks and probably their immediate functional output is conserved. I 
might therefore expect genes involved in a given phenolog to represent a coherent 
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biological module, and thus to be highly interconnected in gene networks. Moreover, one 
might expect that the genes already confirmed to show the signature phenotypes in both 
organisms (e.g., the intersection labeled by k in Figure 4.4) would be even more highly 
interconnected than the genes associated with the signature phenotype in only one 
organism; these latter genes might or might not belong to this sub-network, as multiple 
mechanisms might give rise to the phenotype. Evidence in current gene networks of more 
linkages among the genes in each such intersection would support this notion of 
phenologs recapitulating modular subnetworks. I therefore systematically tested all 
significant phenologs involving yeast and worm genes for the genes’ connectivity in 
available functional networks [15, 17]. I find the network connectivity of genes in 
phenolog intersections to be significantly higher (p < 0.0001; Wilcoxon signed-rank) than 
the phenolog genes outside of the intersections, which nonetheless show significantly 
higher network connectivity than random size-matched gene sets (p < 0.0001) (Figure 
4.7). This indicates that phenologs do identify evolutionarily conserved subnetworks of 
genes relevant to particular phenotypes or diseases, while still predicting new candidate 
genes significantly better than random expectation. 
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 Phenotype1  Phenotype2 n1 n2 k p-value PP
V 




















Hs Zellweger syndrome Sc reduced number of 
peroxisomes 




Hs xeroderma pigmentosum Sc high UVC irradiation 
sensitivity 




Hs susceptible to autism Mm abnormal social 
investigation 




Hs susceptible to neural tube 
defects 
Mm abnormal circulating 
amino acid level 




Hs porphyria Sc damnacanthal 
sensitive 




Mm abnormal heart 
development 
Ce male tale morphology 
abnormal 




















Mm gastrointestinal hemorrhage Ce abnormal body wall 
muscle cell polarization 




Hs breast/ovarian cancer Ce high incidence male 
progeny 








Hs congenital disorder of 
glycosylation 








Mm abnormal olfactory neuron 
morphology 




Hs glycogen storage disease Sc glycogen storage 
reduced 




Hs amyotrophic lateral 
sclerosis 
Sc increased resistance to 
wortmannin 








Mm abnormal endocardium 
morphology 




Hs somatic basal cell 
carcinoma 










TABLE 4.1  EXAMPLES FROM THE >6,000 SIGNIFICANT PHENOLOGS DETECTED 
among human (Hs) diseases and mouse (Mm), yeast (Sc), and worm (Ce) mutant 
phenotypes.  n1 indicates the number of orthologs in organism 1 with phenotype1, 
n2 the number in organism 2 with phenotype2, and k the number in both sets. The 
significance of each phenolog is assessed by the hypergeometric probability (p-
value), the positive predictive value (PPV) when considering multiple testing (1 – 
false discovery rate), and the reciprocal best hit criterion (bold text).  Table from 




FIGURE 4.7  GENES INVOLVED IN PHENOLOGS SHOW ENHANCED 
INTERCONNECTIVITY IN GENE NETWORKS, shown here for worm (top) and 
yeast (bottom) gene networks [17, 20]. All significant yeast-worm phenologs with 
at least 4 orthologs in both the ‘intersection’ and ‘non-intersection’ sets (see 
Methods) were tested for network connectivity, measured as the area under a 
receiver-operator characteristic (ROC) plot as described in [15], with values 
ranging from 0.5 (random network connectivity) to 1 (high network connectivity). 
Genes from phenolog intersections show significantly higher network 
connectivity than genes associated with a phenolog, but outside of the 
intersection, which in turn show significantly higher connectivity than size-
matched random gene sets. Thus, phenologs capture subnetworks or network 
modules informative about a given phenotype pair, and carry predictive value for 
additional genes relevant to the phenotypes. At the left of each box-and-whisker 
plot, the center of the blue diamond indicates the mean AUC across phenologs, 
the top and bottom of the diamond indicate the 95% confidence interval, and the 
accompanying solid vertical line indicates ± 2 standard deviations. The bottom, 
middle, and top horizontal lines of the box-and-whisker plots represent the first 
quartile, the median, and the third quartile of AUCs, respectively; whiskers 
indicate 1.5 times the interquartile range. Red plus signs represent individual 
outliers.  Figure adapted from work in review [42]. 
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Experimental Results 
Experimental confirmation of a yeast model for vertebrate angiogenesis 
The power of the phenolog framework lies in discovery of non-obvious disease 
models. I observed just such a serendipitous phenolog between abnormal angiogenesis in 
mutant mice and reduced growth rate of yeast deletion strains when grown in the 
hypercholesterolemia drug lovastatin (8 mouse genes, 67 yeast, 5 shared, p ≤ 10
-6
; Figure 
4.8). This observation, consistent with the action of lovastatin in reducing tumor-induced 
angiogenesis (e.g., [23]), suggests that budding yeast, which entirely lack blood vessels, 
could potentially model aspects of mammalian vasculature formation, and help to define 
genes affecting this process. In particular, the five shared genes between these processes 
are, in yeast, the mitogen activated protein (MAP) kinases SLT2, PBS2, and HOG1, the 
calcineurin B protein CNB1, and the uncharacterized protein VPS70; the four 
characterized proteins regulate osmosensing and aspects of cell wall organization and 
biogenesis. Strikingly, mutations of their mouse orthologs (MAPK7, MAP2K1, 
MAPK14, PPP3R1, and the prostate-specific membrane antigen PSMA, respectively) all 
show strong angiogenesis defects—e.g., MAPK7 deletion causes defective blood vessel 
and cardiac development [24]; ablation in adult mice leads to leaky blood vessels [25]. 
Similarly, PSMA regulates angiogenesis by modulating integrin signal transduction [26]. 
Thus, this conserved subnetwork of genes was alternately repurposed to regulate 
osmosensing and cell wall biogenesis in yeast cells and proper formation and 




FIGURE 4.8  EXAMPLE OF A NON-OBVIOUS DISEASE MODEL REVEALED BY 
PHENOLOGS: YEAST MUTANTS SENSITIVE TO THE HYPERCHOLESTEROLEMIA 
DRUG LOVASTATIN PREDICT MAMMALIAN ANGIOGENESIS DEFECTS.  The set 
of 8 genes (considering only mouse/yeast orthologs) associated with mouse 
angiogenesis defects and the set of 67 genes associated with lovastatin 
hypersensitivity in yeast significantly overlap, suggesting that the yeast gene set 
may predict angiogenesis genes. This prediction was verified in Xenopus embryos 




Orthology of phenotypes predicts that additional human orthologs of genes 
associated with a phenologous model organism trait are more likely to be associated with 
the human disease. I therefore examined the yeast angiogenesis model for other yeast 
genes (with mammalian orthologs) whose deletion induced sensitivity to lovastatin. Of 
the 62 candidates, three of the corresponding mouse genes were confirmed by literature 
to function in angiogenesis, but had yet to be annotated as such. These genes included the 
known target of lovastatin, HMG-CoA reductase, whose role in angiogenesis has been 
previously observed [27], the sirtuin SIRT1, whose disruption in zebrafish and mice 
caused defective blood vessel formation and blunted ischemia-induced 
neovascularization [28], and the casein kinase Csnk2a1, inhibitors of which inhibit mouse 
retinal neovascularization [29]. Additional genes were involved in other aspects of 
cardiovascular development, such as the gene mitoferrin, being expressed most highly in 
hematopoietic organs, fetal liver, bone marrow, and spleen, and mutations in which block 
terminal erythroid maturation, leading to profound anemia [30]. Similarly, SMAP1 
positively regulates erythrocyte differentiation [31]. Thus, mammalian orthologs of the 
62 yeast lovastatin-sensitivity genes include additional genes relevant to cardiovascular 
development, supporting the notion that a yeast model might predict angiogenesis genes. 
 
In order to more directly evaluate predictions of this phenolog, 13 of the 62 genes 
not already associated with angiogenesis were tested in the frog Xenopus laevis. Using 
whole mount in situ hybridization, my collaborators examined mRNA expression of the 
Xenopus orthologs for patterns relevant to angiogenesis. The gene xSOX12 (the Xenopus 
ortholog of mammalian SOX13, a transcription factor known to regulate T lymphocyte 
differentiation [32] and to be expressed in mouse arterial walls [33]) was prominently 
expressed in the posterior cardinal vein, intersomitic veins, and developing heart, 
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consistent with a role affecting developing vasculature (Figure 4.9). They knocked down 
xSOX12 expression using microinjection of morpholino antisense oligonucleotides (MO) 
and assayed for vasculature defects by in situ hybridization to the vasculature reporter 
genes Erg and XMsr (Figure 4.10).  The knockdown of xSOX12 leads to a strong defect 
in angiogenesis, with morpholino injected animals largely lacking intersomitic and 
posterior cardinal veins. By later stages, hemorrhaging was apparent in morphants due to 
the defective vasculature (Figure 4.11). Thus, xSOX12/SOX13 is a novel regulator of 
angiogenesis, discovered in the absence of any previous functional data linking it to 
angiogenesis, on the basis of orthology between mouse angiogenesis defects and yeast 
lovastatin sensitivity. Notably, these data also demonstrate that differentiation both of 




FIGURE 4.9  IN SITU HYBRIDIZATION SHOWS XSOX12 EXPRESSION IN VEINS AND 






FIGURE 4.10  MORPHOLINO (MO) KNOCKDOWN OF XSOX12 INDUCES DEFECTS IN 
VASCULATURE, measured using in situ hybridization versus two independent 
markers of the vasculature, the angiogenesis-regulating transcription factor Erg 
(defects observed in 31 of 49 animals tested) and the angiotensin receptor 
homolog XMsr (12 of 19 animals tested). Such defects are rare in untreated 
control animals and 5 base pair mismatch morpholino (MM) knockdowns (0 of 22 
control animals tested with XMsr, 2 of 46 tested with Erg; 5 of 28 MM animals 




FIGURE 4.11  HEMORRHAGING IS APPARENT IN STAGE 45 XENOPUS EMBRYOS DUE 
TO DYSFUNCTIONAL VASCULATURE FOLLOWING XSOX12 MORPHOLINO 
KNOCKDOWN (12 of 50 animals tested; 2 also showed unusually small hearts 
with defective morphology; right-hand panel magnifies yellow boxed region in 
middle panel), but is rare in control animals (1 of 45 tested untreated animals, 1 of 
22 xSOX12-MM knockdown animals tested). All phenotypes in Figures 4.10 and 
4.11 are significantly different from controls by chi-square tests (p < 0.001).  
Figure adapted from work in review [42]. 
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Experimental confirmation of a worm model for neural tube defects 
Given a phenolog for a human disease, any approach for associating more genes 
with the model organism trait, e.g., a genetic screen, will suggest new human disease 
gene candidates. I used this approach and a phenolog between abnormal C. elegans cilia 
morphology and mouse neural tube defects—consistent with a known role for cilia in 
neural tube formation [34]—to identify new genes affecting vertebrate neural tube 
closure (Figure 4.12). Defects in neural tube closure are among the most common and 
debilitating human birth defects, afflicting nearly 1 in 1,000 live births world-wide [35], 
yet they have a complex genetic basis and knowledge of the underlying genes is still 
incomplete.  We first tested a direct prediction of the phenolog to confirm that 
knockdown of the vertebrate intraflagellar transport gene IFT140 causes defective 
ciliogenesis and failure of neural tube closure in developing Xenopus embryos (Figure 
4.13). We then applied the emerging technique of network-guided genetics [17] to 
prioritize the transcription factor daf-19, a master regulator of worm ciliogenesis, as the 
gene most likely to show a similar effect (based on known genetic interactions to the cilia 
morphology defect genes). We knocked down the Xenopus ortholog of this gene, RFX2, 
and observed a defect in the developing neural tube at stage 20 (Figure 4.13), confirming 
RFX2’s association with neural tube defects for the first time in a vertebrate. As RFX2 is 
a transcription factor, it might potentially control many downstream processes; analysis 
of an early marker of ciliated cell fate specification (TEX15 [36]) confirms that ciliated 
cells are intact in the RFX2 knockdown animals (Figures 4.14). Characterization of the 
precise defects of IFT140 and RFX2 knockdown in Xenopus shows normal deployment 
of basal bodies but marked reduction of cilia on multi-ciliated epithelial cells if either 
gene is knocked down (Figure 4.13). Given the good mechanistic and genetic agreement 
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between Xenopus and mammalian neural tube closure [37], there is thus a high likelihood 




FIGURE 4.12  SCHEMATICALLY REPRESENTATION OF THE VALIDATION OF TWO NEW 
NEURAL TUBE DEFECT GENES PREDICTED BY PHENOLOGS AND GENE 





FIGURE 4.13  MORPHOLINO KNOCKDOWNS OF XENOPUS GENES RFX2 AND IFT140 
SHOW STRONG NEURAL TUBE DEFECTS (left column), in contrast to control 
animals. (RFX2-MO, 41 of 43 animals tested; IFT140-MO, 46 of 52 tested; 
untreated control, 0 of 55 tested.) Immunofluorescence of the Xenopus ciliated 
epithelium from IFT140 or RFX2 morpholino knockdown animals reveals normal 
deployment of basal bodies (centrin marker) but abnormal or missing cilia (alpha-






FIGURE 4.14  RFX2-MO KNOCKDOWN ANIMALS SHOWS THAT CILIATED CELLS ARE 
INTACT, BUT LACK CILIA as shown in a representative in situ hybridization 
versus TEX15, a marker of ciliated cell fate specification [36]. The numbers of 
ciliated cells visible per embryo did not differ significantly between control and 
RFX2-MO embryos (13 control embryos were scored, with 6 showing high 
numbers of ciliated cells, 4 medium, 3 low; 11 RFX-MO embryos were scored 
showing 4 high, 6 medium, 1 low; no significant difference by chi-square test.)  





Phenologs reflect the innate modularity of gene systems and help illuminate the 
prolific adaptive reuse of conserved genetic elements because they identify sets of genes 
that maintain a shared relationship across varied biological contexts.  Within this 
framework, it is possible to address questions like, “Does a genetic module maintains a 
recognizable identity in single-cell yeast and in the blood vessels of vertebrates?”  This 
approach identifies genetic modules that would otherwise be obscured when their 
rewiring with other downstream modules leads to divergent phenotypic outcomes in other 
organisms.  The participation of multiple genetic modules in determining a shared 
phenotypic outcome may help explain why the genes in the intersection of two 
phenotypes are so tightly interlinked even relative to other genes associated with the 
same phenotype (Figure 4.7).  I propose that one possible explanation for this trend is 
that phenologs are identified on the basis of a shared, conserved genetic module, but that 
other organism-specific modules (or organism-specific relationships among modules) 
determine the specific phenotypic outcome (Figure 4.15).  When randomly sampling 
from the non-intersecting genes, my algorithm would sample only one module in the 
intersection, but would sample multiple modules among the rest of the genes involved in 
the phenotype, which would reduce the relative density of functional links among the 
genes, as measured by the area under the ROC curve.  In the future, with a wider 
sampling of phenotypic data across taxa, it may eventually be possible to track the 
functional coherence of sets of genes over time, and piece together how they are rewired 
for different purposes in various organisms.  Ultimately, this wider, comparative view 
will give greater insight into specific mechanisms, since it will capture not just the 




FIGURE 4.15  PROPOSED MODEL TO EXPLAIN GREATER FUNCTIONAL COHERENCE 
AMONG ORTHOLOGS INVOLVED IN BOTH PHENOTYPES RELATIVE TO 
ORTHOLOGS INVOLVED IN A SINGLE PHENOTYPE ( see Figure 4.7).  Phenologs 
may be identified primarily by the overlap of a single genetic module 
(overlapping orthologs are represented by blue circles, functional relationships by 
blue lines.).  However, in each organism multiple additional non-conserved 
modules may be involved in the orthologous phenotype (represented by circles of 
various other colors), including downstream modules that give rise most directly 
to the organism specific phenotype.  Sampling of the non-overlapping orthologs 
will reveal fewer functional links since members of different modules will have 
fewer functional links between them.  However, as a set they remain somewhat 





This research shows that phenologs provide a rich framework for comparing 
mutational phenotypes with potential for finding non-obvious models of human disease.  
The phenologs also naturally identify candidate genes that have a clear relationship to 
human disease. This will facilitate the study of underlying mechanisms of diseases in 
simple, tractable model organisms with the confidence that the research will apply 
directly to understanding aspects of complex human diseases.  To that end, the phenolog 
approach provides a quantitative heuristic for estimating the likely utility of a chosen 
organism as a model for a disease of interest.  Additional experimental work will be 
needed to evaluate how useful this heuristic will be. 
 
The combination of phenologs with the method of network guided genetics, 
explored in the previous chapter, has already identified a neural tube gene, RFX2, that is 
a very strong contender for playing a role in human neural tube defects.  A more 
thorough exploration of the synergy between these two approaches may find refinements 
that provide even more impressive predictions. 
 
Phenologs identify closely associated genes and provide insight into the systems 
involved in a phenotype, but detailed molecular work is still necessary to determine the 
exact mechanisms that ultimately lead to the phenotypic effects of the disruption of these 
systems.  To this end, I have provided a web application to interactively search for 
phenologs, available at http://www.phenologs.org, making both the algorithm and the 
data readily available to those who study specific diseases or biological systems.  At the 
beginning of the age of sequencing, identifying orthologous genes would have been 
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nearly impossible without algorithms like Needleman-Wunsch [38], Smith-Waterman 
[39], or BLAST [40].  However, prior to GenBank [41] and other sequence databases, 
collecting sequence data reported in the literature would make orthologous genes difficult 
to track down.  Hopefully, this work provides an initial algorithm for identifying 
orthologous phenotypes and will further motivate the creation and use of a standard 
repository of gene-phenotype associations for all organisms, so that phenologs and their 
underlying genetic systems will be more readily identified. 
 
This chapter has been reworked and expanded from a submitted paper [42] that is 
currently under review. 
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Chapter 5: Putting the pieces together 
Widespread genome sequencing has provided a substantial list of the parts that 
make up living organisms.  In some cases, we already know where those pieces fit 
together, in other cases, there is still much work to be done; particularly to work out how 
molecular sequences and their defects lead to specific, macroscopic morphologies and 
phenotypes.  If we approach biology like a jigsaw puzzle, we can see that genome 
sequencing has defined many of the pieces of the puzzle and basic research has already 
found many of the edge pieces that frame the work that remains to be done.  However, 
much labor will be necessary to place the remaining pieces and to understand how 
individual processes work together as a whole.  It is my hope that the predictive 
approaches that have been developed here will contribute to associating poorly 
understood genes with their correct biological context, which will facilitate targeted 
research that addresses the mechanistic, molecular level details and yet play a role in 
connect the details to a unified biological understanding that bridges the various 
biological processes and functions, both within a given organism and, eventually, across 
the diversity of life.   
 
To that end, I have developed: a tool for understanding cellular level events 
(chapter 2), a method for associating genes with organismal phenotypes (chapter 3), and, 
finally, a framework that leverages a comparative approach to learn more about the unity 
and diversity of the mechanisms that function in many species (chapter 4).  Using these 
tools is analogous to sorting pieces of a puzzle according to their color and texture prior 
to assembling them.  My disappointing attempt to predict the export adaptor of the small 
subunit of the ribosome suggests that our current tools may not yet be able to predict the 
specific mechanisms by which the biological puzzle will fit together.  However, my 
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subsequent papers has shown three different domains in which current knowledge can be 
leveraged to predict genes associated with a number of biological processes.  The 
adoption of these tools by other researchers has the potential to further accelerate the pace 
of the collection of biological knowledge by prioritizing candidate genes in intuitively 
understandable, broadly applicable, quantitative ways that illuminate their relevance to 
individual biological processes of interest. 
 
In particular, I hope that the phenolog approach and supporting web application 
will provide a very practical tool that helps reinforce the important contributions that can 
be made by integrating comparative methods in the normal work flow of molecular and 
cellular biology.  By providing a pragmatic motivation for the collection of gene-
phenotype data across many taxa, I hope that the collected data will eventually facilitate 
comparative studies across a range of spatial and temporal scales (e.g. developmental, 
behavioral, physiological, and metabolic) and grant us a better understanding of how the 
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